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The present study sought to examine the feasibility and preliminary efficacy
of a computerized behavioral activation treatment for depressive disorders (IMMBA), while also investigating potential mechanisms of action involved in the
treatment of depression through the use of behavioral activation.

Nine adults who

met criteria for either Major Depressive Disorder or Dysthymic Disorder were
recruited from Kalamazoo, Portage, and surrounding areas in Southwestern Michigan.
All participants received ten sessions of IMM-BA treatment.

Symptoms

of

depression and related information were assessed at pretreatment and one-week, onemonth, three-month, and six-month follow-up through the use of the Beck Depression
Inventory - II (BDI-II), the Revised Hamilton Rating Scale for Depression (RHRSD),
the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID), the
Behavioral Activation for Depression Scale (BADS), the Automatic
Questionnaire (ATQ), and the Quality of Life Scale (QOLS).

Thoughts

It was hypothesized

that I M M - B A treatment would lead to significant decreases in symptoms of
depression and positive changes in quality of life. Furthermore, it was hypothesized
that changes in the patterns and nature of overt behavior of participants would be the
primary mechanism by which treatment effects were observed.
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CHAPTER I
INTRODUCTION

Major Depressive Disorder is a mood disorder characterized by a two-week
period of either depressed mood or anhedonia, accompanied by at least four
additional symptoms, including (1) weight loss or weight gain, (2) insomnia or
hypersomnia, (3) psychomotor retardation or agitation, (4) fatigue or loss of energy,
(5) feelings of worthlessness or guilt, (6) diminished ability to think or concentrate,
and (7) recurrent thoughts of death or suicide (American Psychiatric Association,
2000). This debilitating disorder affects 20.9 million (9.5%) American adults each
year (National Institutes of Mental Health, 2009) and 121 million people worldwide
(World Health Organization, 2009). Dysthymic Disorder is another common mood
disorder, characterized by a two-year period during which an individual experiences
depressed mood more often than not, accompanied by at least two additional
symptoms, including (1) poor appetite or overeating, (2) insomnia or hypersomnia,
(3) low energy or fatigue, (4) low self-esteem, (5) poor concentration or difficulty
making decisions, and (6) feelings of hopelessness (American Psychiatric
Association, 2000). The lifetime prevalence of Dysthymic Disorder is estimated to be
6%, with 3% of the population suffering from Dysthymic Disorder at any given time
(American Psychiatric Association, 2000). In addition to the presence of unpleasant
symptoms that characterize these depressive disorders, these disorders often also have
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substantial negative impacts on the social, academic, physical, familial, occupational,
and sexual functioning of those individuals suffering from these disorders.
Additionally, depressive disorders are costly on a societal level, in terms of
diminished productivity in the workplace, value of lifetime earnings lost due to
suicide, and expenses associated with treatment (National Institutes of Mental Health,
2009).
Although the costs of depressive disorders are immense, at both an individual
and societal level, fewer than 25% of all individuals suffering from depressive
disorders have access to effective treatment (World Health Organization, 2009).
Interestingly, this statistic cannot be accounted for by a lack of empirically supported
treatments for depressive disorders. In an extensive review and evaluation of
treatments for common psychological disorders, Chambless and colleagues (1998)
determined that three treatments for depressive disorders (behavior therapy, cognitive
therapy, and interpersonal therapy) met criteria to be considered "well-established"
treatments and an additional five treatments for depressive disorders (brief dynamic
therapy, cognitive therapy for geriatric patients, reminiscence therapy for geriatric
patients, self-control therapy, and social problem-solving therapy) met criteria to be
considered "probably efficacious" treatments. Furthermore, although the clinical
efficacy of antidepressants above that observed by individuals receiving placebos in
medication-based clinical trials has recently been contested (e.g. Kirsch, Deacon,
Huedo-Medina, Scoboria, Moore, & Johnson, 2008), antidepressants are also a
commonly considered to be an additional effective treatment for depressive disorders.
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A number of variables may account for the alarming lack of access to
effective treatment for individuals suffering from depressive disorders. Financial
burdens on the individual seeking treatment may play a substantial role, as services
may only be available during hours that an individual is scheduled to work (Alegrfa,
Chatterji, Wells, Cao, Chen, Takeuchi, et al., 2008) or as individuals may have
insurance plans that limit coverage for mental health services or require high per
session copays (Castellblanch & Abrahamson, 2003). Lack of access or desire to
seek specialty services, coupled with long wait times for individuals who do choose
to seek specialty services, also impacts access to treatment (Coyle, Doherty,
Matthews, & Sharry, 2007; Pomerantz, Cole, Watts, & Weeks, 2008). Although the
United States has some of most developed mental health care systems in the world,
there are still only 10.5 psychiatrists, 14 psychologists, 32.95 psychiatric nurses, and
15.7 social workers per 100,000 people (Saxena, Thornicroft, Knapp, & Whiteford,
2007). Lack of availability of qualified mental health practitioners may be
compounded by living in a rural location or in an area that is typically underserved in
terms of mental health services (McGinty, Saeed, Simmons, & Yildirim, 2006). Even
if qualified mental health practitioners are available, the locations in which these
individuals practice may be inconvenient to individuals who would benefit f r o m
mental health services. A limited number of treatment outcome studies have
addressed this issue by making services available in more convenient locations,
including homes of individuals seeking services (e.g. Yon & Scogin, 2009) and local
supermarkets (e.g. Swartz, Shear, Frank, Cherry, Scholle, & Kupfer, 2002), however
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availability of services in non-traditional locations has yet to become common
practice. In addition to all of these factors, other issues influencing the likelihood that
someone will receive effective treatment for their depressive symptoms include the
extent to which they are impacted by social stigmas associated with seeking mental
health services, mistrust of mental health professionals on the part of the individual
seeking services, individual demographic variables (e.g. race, age), and lack of
accurate screening for depressive disorders in primary care settings (Alegria,
Chatterji, Wells, Cao, Chen, Takeuchi, et al., 2008; Coyle, Doherty, Matthews, &
Sharry, 2007; Pandiani, Banks, Bramley, Pomeroy, & Simon, 2002; Pomerantz, Cole,
Watts, & Weeks, 2008).
Information available at the present time suggests that the reasons individuals
are not receiving effective treatments for depressive disorders has little to do with the
existence of effective treatments for depression. A number of treatments with
demonstrated efficacy exist for this debilitating group of mood disorders. Instead, the
primary barriers to treatment include dissemination of principles of effective
assessment to primary care providers and dissemination of principles of effective
treatment to mental health practitioners, the existence of ample mental health
practitioners to meet demand, and the presence of affordable and local treatment
options. These barriers necessitate a novel approach to the treatment of depressive
disorders.
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CHAPTER II
LITERATURE REVIEW

Description

of Behavioral

Activation.

As mentioned previously, behavior

therapy is one of three well-established treatments for depressive disorders.
Encompassed within behavior therapy is a specific approach to treatment, known as
behavioral activation. Early versions of behavioral activation focused primarily on
encouraging patients to engage in activities that are commonly assumed to be
pleasant, such as taking a walk or having dinner with a friend. A number of more
nuanced, contemporary iterations of behavioral activation have since developed, each
of which have some unique aspects, but most of which include a few common
features. First, all versions of behavioral activation include some type of scheduling
of various daily activities that have a functional relationship to the symptoms of
depression of the individual seeking treatment. These activities may have a number
of intended effects, including evoking a sense of mastery and/or pleasure (Jacobson,
Dobson, Truax, Addis, Koerner, Gollan, et al. 1996), disrupting patterns of avoidance
(Jacobson, Martell, & Dimidjian, 2001), regulating the daily routines of the individual
in treatment (Jacobson, et al., 2001), and/or helping the individual to behave in a way
that is more consistent with his or her values (Lejuez, Hopko, & Hopko, 2001).
Second, all versions of behavioral activation emphasize the importance of engaging in
scheduled and unscheduled daily activities, regardless of one's mood or desire to
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engage in these activities (Jacobson, et al., 2001). Behavioral activation is based on
the premise that in order to feel differently, one must first behave differently, instead
of the premise that in order to behave differently, one must first think and feel
differently (Jacobson, et al., 2001). Finally, most contemporary behavioral activation
approaches include supplemental behavioral treatment components intended to
address specific maintaining or exacerbating factors of the symptoms of depression
for the individual seeking treatment (Jacobson, et al., 1996; Lewinsohn, Sullivan, &
Grosscup, 1980). These components may include training in assertiveness, social
skills, relaxation, time management, behavioral contracting, problem-solving, goalsetting, distraction from distressing cognitions and rumination, and implementation of
graded task assignments (Jacobson, et al., 1996; Jacobson, et al., 2001; Lejuez, et al.,
2001; Lewinsohn, et al., 1980).
Theoretical

Framework

of Behavioral

Activation.

The theoretical

underpinnings of behavioral activation are rooted in radical behaviorism, a theoretical
framework elucidated by B. F. Skinner and his contemporaries. Based on this
framework, a number of authors have hypothesized about factors that may be
responsible for the maintenance of behaviors commonly observed in individuals
suffering from depressive disorders. Ferster (1973) was one of the first individuals to
identify behavior patterns of depressed individuals that are now targeted in behavioral
activation. The model of depression he put forth identifies two patterns that
characterize the behavior of depressed individuals: (1) a low rate of positively
reinforced social behaviors, such as eye contact and verbal communication, and (2) a
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high rate of escape and avoidance behaviors, such as avoidance of social situations or
requests for help. In turn, Ferster hypothesized that a decreased amount of activity on
the part of the depressed individual would lead to a weakening in the connection
between an individual's action and the reinforcers sustaining them, which may further
exacerbate symptoms of depression. Within his model, Ferster also outlined a
number of possible etiologies of symptoms of depression, some of which reflect the
prevalence of traditional psychoanalytic theories at the time (e.g. fixated personality
development), but were discussed in a more behaviorally-oriented framework, and
others of which seem to arise out of a solely behavioral framework (e.g. low rates of
positively reinforced behavior due to a loss of a potent reinforcer).
From Ferster's model, which was focused primarily on discussions of possible
etiology of depression and descriptions of the behavior of depressed individuals,
Lewinsohn (1974) developed a model of depression upon which early formulations of
behavioral activation were based. In Lewinsohn's model, a low rate of responsecontingent reinforcement is believed to be an important antecedent in the
development of symptoms of depression, which in turn results in the low rates of
behavior observed in depressed individuals, as a paucity of reinforcement leads to
adaptive behaviors being extinguished. Additionally, this lack of reinforcement is
hypothesized to lead to an increase in depressed mood and dysphoric feelings
(Lewinsohn, et al., 1980). Response-contingent reinforcement is believed to be a
function of three factors: (1) the number of events believed to be positively
reinforcing to the affected individual, (2) the availability of these positively
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reinforcing events in the affected individual's environment, and (3) the availability of
a behavioral repertoire within the affected individual that is needed to obtain positive
reinforcement from the environment. Furthermore, the potency of reinforcing events
may also be reduced. Additionally, Lewinsohn, et al. (1980) hypothesized that
punishment may also play an important role in the etiology and maintenance of
depression, such that there may be a high rate of punishing events occurring in the
individual's environment and the individual may lack the necessary repertoire to
reduce the frequency or intensity of these punishing events. From this model,
Lewinsohn developed the first iteration of behavioral activation, which focused on
monitoring pleasant and unpleasant events, scheduling pleasant events, and teaching
social skills. While this approach to the treatment of depression had some limited
success, critics of this approach note that it pays little attention to increases in
behaviors maintained by negative reinforcement (Kanter, Callaghan, Landes, Busch,
& Brown, 2004). Furthermore, contemporary iterations of behavioral activation are
rooted in functional contextualism, which expands beyond the model proposed by
Lewinsohn and includes a specific focus on the idiographic, functional relationship
between specific activities and symptoms of depression (Kanter, et al., 2004). While
this is an improvement upon the initial theoretical frameworks upon which behavioral
activation is based, Kanter, et al. (2004) still note that in-vivo application is another
important component of a more complete behavioral treatment, and thus have
directed some of their attention to supplementary approaches (e.g. Functional
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Analytic Psychotherapy) to the treatment of depression in order to address this
component.
It follows naturally from historical and contemporary behavioral theories of
the etiology and maintenance of symptoms of depression that the hypothesized
mechanism of action in behavioral activation is changes in overt behavior. Authors
have put forth two hypotheses about specifically how changes in overt behavior may
decrease symptoms of depression. First, addressing qualitative and quantitative
deficits in overt behaviors may increase the availability of reinforcers in the
environment of the depressed individual (Hopko & Mullane, 2008), which has been
called the "activation hypothesis" by Jacobson and colleagues (1996). A study
conducted by Hopko and Mullane (2008) found that mildly depressed individuals
engaged in fewer physical, educational, and social activities and more employment
activities than non-depressed individuals. These data suggest that both amount of
behavior emitted, as well as types of behavior emitted, are relevant when developing
interventions to address symptoms of depression. As depressed individuals engage in
activities prescribed as part of behavioral activation treatment, they are likely to
encounter reinforcement for non-depressed behavior, which in turn increases the
likelihood that they will engage in non-depressed behavior and decreases the
likelihood that they will engage in depressed behavior in the future (Lejuez, et al.,
2001). Second, changes in overt behavior may decrease symptoms of depression
through countering avoidance patterns that are commonly observed in individuals
experiencing depression (Lejuez, et al., 2001). Depressed individuals frequently
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engage in behaviors that serve to reduce or avoid imminent distress, at the expense of
eliminating access to potential reinforcers (Hollon, 2001; Jacobson, et al., 2001).
While these behaviors may be functional in the short-term, they ultimately exacerbate
symptoms of depression over the course of time, in addition to creating new
difficulties in other areas of the depressed individual's life (e.g. social, occupational)
(Jacobson, et al., 2001). Behavioral activation may work through countering these
patterns of avoidance and withdrawal, which creates the possibility of encountering
sources of reinforcement (Hollon, 2001; Jacobson, et al., 2001).
Unfortunately, studies that have explicitly attempted to examine potential
mechanisms of action in behavioral activation are limited. Jacobson and colleagues
(1996) were the first group to attempt to examine mechanism of action in their
component analysis of cognitive-behavioral therapy for depression. Participants in
their study were assigned to three treatment conditions: behavioral activation alone,
behavioral activation plus treatment components aimed at modifying negative
automatic thoughts, and behavioral activation plus treatment components designed to
address negative automatic thoughts and maladaptive core schemas. Participants in
all three conditions demonstrated increases in frequency and perceived enjoyment of
pleasant activities, decreases in negative automatic thoughts, and decreases in
attribution of negative life events to internal, stable, and global factors. In terms of
temporal relationships, Jacobson, et al. (1996) noted two interesting observations.
First, participants in the behavioral activation condition who experienced changes in
their cognitive schemas earlier in treatment displayed greater decreases in their
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symptoms of depression later in treatment. Second, participants in the condition that
included behavioral activation and treatment components targeting negative
automatic thoughts and maladaptive core schemas who increased their frequency of
pleasant events earlier in treatment experienced greater decreases in their symptoms
of depression when measured later in treatment. These observations conflict with the
hypothesis that changes in overt behaviors are responsible for changes in symptoms
of depression in behavioral activation.
Gaynor and Harris (2008) attempted to investigate potential mechanisms of
action of behavioral activation at more frequent time intervals than used in the
Jacobson, et al. (1996) study. Gaynor and Harris (2008) noted that one of the
potential limitations regarding the way in which Jacobson, et al. (1996) examined
potential mediators of treatment effects was that variables pertaining to potential
mediators were only measured at pre-treatment, mid-treatment, and post-treatment,
which may obscure changes that were occurring on a week-to-week basis. Gaynor
and Harris (2008) presented data on four depressed adolescents who experienced
remission of symptoms of depression following a course of values-based behavioral
activation. Potential mediators of changes in symptoms of depression were measured
on a weekly basis through the use of the Negative Self-Concepts and Negative
Expectations subscale of the Automatic Thoughts Questionnaire and through the
active coping and behavioral disengagement subscales of the COPE. Three of the
four participants demonstrated increases in activation when the values-based
behavioral activation was introduced and for two of the four participants, the

introduction of values-based behavioral activation preceded changes in symptoms of
depression. This suggests that for these two participants, increased activation is a
plausible mediator of observed treatment effects. Furthermore, changes in
dysfunctional thinking did not appear to be a plausible mediator for any of the four
participants.
Behavioral

Activation

Treatment Outcome Data.

Although research on

treatment approaches resembling contemporary behavioral activation or components
of contemporary behavioral activation has been occurring since the late 1960s
(Kanter, et al., 2004), behavioral activation was not recognized as a standalone
treatment of depression until the aforementioned seminal component analysis study of
cognitive-behavioral therapy for depression conducted by Jacobson and colleagues
(1996). One hundred and forty-nine outpatients diagnosed with major depression
were randomly assigned to one of three treatment conditions. The behavioral
activation (BA) condition included monitoring of daily activities and ratings of
mastery and pleasure associated with these activities, graded task assignments,
cognitive rehearsal of scheduled activities, social skills training, and behavioral
interventions for specific problems. The activation and the modification of
dysfunctional thoughts (AT) condition included all the components of the BA
condition, plus a specific focus on the modification of automatic dysfunctional
thoughts and cognitive distortions. The cognitive-behavioral therapy (CT) condition
included all the components of the AT condition, as well as a focus on addressing
broader patterns of thought that are believed to be responsible for automatic
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dysfunctional thoughts and cognitive distortions. Of the 149 individuals randomized
to one of these three treatment conditions, 137 individuals completed treatment. At
the end of acute treatment, all three interventions performed equally across all
outcome measures, including the BDI, HRSD, and measures of dysfunctional
thinking. All three interventions also had comparable effects at six-month follow-up,
indicating that all three were equally as successful in terms of relapse rates.
Furthermore, a subsequent data analysis conducted by Gortner, Gollan, Dobson, and
Jacobson (1998) showed that this finding regarding relapse rates was maintained at
two-year follow-up.
Although numerous smaller behavioral activation treatment outcome studies
were conducted subsequent to the Jacobson, et al. (1996) treatment outcome study,
the next large-scale investigation of the efficacy of behavioral activation was
conducted by Dimidjian and colleagues in 2006. Two hundred and forty-one adults
with major depressive disorder were randomized to one of four conditions:
behavioral activation (BA), cognitive therapy (CT), antidepressant medication
(ADM), or pill placebo (PLA). The BA condition involved an expanded version of
the behavioral activation protocol utilized in the Jacobson, et al. (1996) study and
included additional components to address avoidance behaviors, regularized routines,
and rumination. The CT condition targeted behavioral dysfunction, situation-specific
negative thinking and cognitive distortions, and underlying maladaptive cognitive
schemas. The A D M condition involved the use of antidepressant medications
administered under triple-blind conditions for the first eight weeks of the study and

single-blind conditions for the remaining eight weeks of acute treatment. In this
condition, participants saw a pharmacotherapist on a weekly basis for the first four
weeks of treatment and then on a bi-weekly basis for the remainder of the acute
treatment phase. As with the A D M condition, the PLA condition involved the use of
a pill placebo administered under triple-blind conditions for the first eight weeks of
treatment. After eight weeks, the blind was broken and participants in the PLA
condition were allowed to select any of the active treatments being provided in the
study. Of the 241 individuals randomized to treatment, 172 were treatment
completers. The rate of attrition was significantly higher in the A D M condition, in
comparison to the BA and CT conditions. Significant improvement among "lowseverity" participants on the BDI and HRSD was observed across all active treatment
conditions, with no differential outcomes observed between groups. Among "highseverity" participants, B A and A D M significantly outperformed CT. Furthermore,
BA led to greater remission rates and lower attrition rates than ADM. Data from this
study suggesting that BA may be a more efficacious treatment than CT for more
severely depressed individuals was further supported in a reanalysis of the Dimidjian,
et al. (2006) data conducted by Coffman and colleagues (2007). Coffman, et al.
(2007) examined data from a subset of individuals randomized to the CT condition
who had an extreme non-response to cognitive therapy. A number of common
characteristics among these individuals were identified, including longstanding
depression symptoms, significant functional impairment, and difficulties with primary
support groups. Interestingly, individuals with similar characteristics who were
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assigned to the BA condition did not experience the same extreme non-response to
behavioral activation therapy, providing further support for the hypothesis that
behavioral activation may be particularly helpful for individuals endorsing severe
levels of depressive symptoms.
The literature examining the efficacy of behavioral activation has been
summarized in three recent meta-analyses. Spates, Pagoto, and Kalata (2006)
conducted a qualitative and quantitative analysis of eight studies investigating
behavioral activation from the Jacobson, et al. (1996) study through studies
conducted in 2006. Studies were evaluated based on seven "gold standards" for
treatment outcome studies outlined by Foa and Meadows (1997) and based on the
Agency for Health Care Policy and Research (AHCPR) standards for level of
evidence supporting health care interventions. Furthermore, effect sizes for each of
the studies included in the meta-analysis were also conducted. On average, the
studies included in the meta-analysis met five out of the seven criteria outlined by Foa
and Meadows (1997) and achieved either an " A " or "B" rating based on the AHCPR
standards, suggesting that the studies included in the meta-analysis were of relatively
high quality. Effect sizes for improvement in symptoms of depression, as measured
by the Beck Depression Inventory, ranged from medium to very large at posttreatment and small to very large at follow-up. Of note, six of eight studies had very
large effect sizes at post-treatment and five of eight studies had very large effect sizes
at follow-up. Effect sizes for improvements in symptoms of depression, as measured
by the Hamilton Rating Scale for Depression, ranged from large to very large at both
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post-treatment and follow-up.

Attrition rates for studies included in the meta-

analysis ranged f r o m 9% to 33%, with a mean of 18.71%, which is comparable to
those observed in treatment outcome studies utilizing other treatment approaches for
depression. Based on these data, the Spates, et al. (2006) concluded that the quality
of existing treatment studies for behavioral activation is relatively high and that the
data are strongly suggestive that it is an efficacious treatment for depression.
Ekers, Richards, and Gilbody (2007) conducted a subsequent meta-analysis of
the behavior therapy literature that reviewed seventeen randomized controlled trials
involving 1,109 subjects. Twenty studies conducted prior to January 2006 were
initially identified for inclusion, however three were ultimately eliminated f r o m the
data analysis due to insufficient data reporting. The meta-analysis demonstrated large
effect sizes favoring behavior therapy when compared to waitlist/control, brief
psychotherapy, and supportive therapy conditions. No differences were observed in
treatment outcome data between behavior therapy and cognitive/cognitive-behavioral
therapy. Based on these data, Ekers, et al. (2007) concluded that behavior therapy is
an effective treatment for depression that may have the additional advantage of being
a particularly parsimonious treatment that is relatively simple to deliver.
Finally, Cuijpers, van Straten, and Warmerdam (2007) conducted a metaanalysis looking more specifically at the effects of activity scheduling on symptoms
of depression. Sixteen studies involving 780 subjects conducted between 1966 and
March 2005 were included in their meta-analysis. The authors noted that the quality
of many of the studies included in their analysis was not optimal, although many of
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the studies did include blinding of individuals who were assessing outcome. Dropout
rates ranged from 2% to 39% across the studies that reported this information. The
pooled effect sizes between activity scheduling and control conditions, activity
scheduling and other psychological treatments, and activity scheduling and cognitive
therapy were 0.87, 0.13, and 0.02, respectively. These data indicate a large effect size
favoring activity scheduling in comparison to control conditions and a non-significant
effect size favoring activity scheduling when compared to alternative psychological
interventions. Changes from post-treatment to follow-up in the activity scheduling
conditions were non-significant, suggesting that improvements in symptoms of
depression were maintained. Based on these data, Cuijpers, et al. (2007) concluded
that activity scheduling is a viable treatment option for symptoms of depression that
performs comparably to alternative psychological treatments.
When considering the literature as a whole, it appears as though behavioral
activation is an efficacious treatment for depression. Furthermore, in considering
individual studies, behavioral activation seems to be effective for a variety of
populations (e.g. university students, elderly individuals), in a variety of formats (e.g.
single-session, individual, group), and for depression that is co-morbid with other
conditions and illnesses (e.g. cancer, obesity) (Gavvrysiak, Nicholas, & Hopko, 2009;
Hopko, Bell, Armento, Hunt, & Lejuez, 2005; Houghton, Curran, & Saxon, 2008;
Pagoto, Bodenlos, Schneider, Olendzki, Spates, & Ma, 2008; Porter, Spates, &
Smitham, 2004; Yon & Scogin, 2009). However, much of the research in these areas
is more limited, suggesting that future replications of these studies are indicated.
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Computerized

Treatments for Depressive

Disorders

Treatment Outcome

Data.

Although researchers have been creating programs designed to replicate therapeutic
interactions since the 1960s, Selmi, Klein, Greist, Sorrell, and Erdman (1990) were
the first group to conduct an empirical investigation of the efficacy of a computerized
treatment for depression. Thirty-six participants with major or minor depressive
disorder were randomly assigned to a computer-administered cognitive-behavioral
therapy condition, a therapist-administered cognitive-behavioral therapy condition, or
a wait-list control condition. The two active treatment conditions consisted of six
sessions of therapy focusing on the relationship between automatic thoughts and
emotions, increasing mastery and pleasure of daily activities, techniques to control
automatic thoughts, and analysis of core beliefs. Participants assigned to the wait-list
control condition were told that they would be allowed to begin treatment after
fourteen weeks. There were no dropouts in any of the three conditions. Both active
treatment conditions demonstrated statistically significant improvements in
comparison to the control condition on the BDI, HRSD, ATQ, and depression and
global scales of the SCL-90. These improvements were maintained at two-month
follow-up.
Since the Selmi, et al. (1990) study, two primary computerized treatments for
depression (Overcoming Depression

and Beating the Blues) have emerged, although

other computerized treatments for depression (e.g. ODIN, MoodGYM)

have also been

empirically tested and will be discussed briefly. The initial investigation of the
efficacy of the Overcoming

Depression

computer-assisted CBT program was

conducted by Bowers, Stuart, MacFarlane, and Gorman (1993). Twenty-two
inpatients diagnosed with major depression were assigned to one of three conditions:
therapist-delivered CBT plus treatment-as-usual, computer-assisted CBT plus
treatment-as-usual, or treatment-as-usual alone. Treatment-as-usual included the
administration of antidepressant medications and participation in therapeutic activities
offered on the inpatient unit (e.g. milieu therapy, vocational rehabilitation). The
therapist-delivered CBT condition involved treatment-as-usual, plus eight sessions of
CBT administered over two weeks by a therapist. The first four sessions of therapy
focused on behavioral interventions (e.g. activity scheduling, graded task
assignments) and the final four sessions focused on identifying, monitoring, and
challenging negative automatic thoughts and cognitive distortions. The computerassisted CBT involved treatment-as-usual, plus eight sessions of CBT administered
by the Overcoming

Depression

computer program. The Overcoming

Depression

program focused on psychoeducation about depression and modifying negative
automatic thoughts and cognitive distortions. Of note, it did not include the
behavioral interventions used in the therapist-delivered CBT condition. There were
no dropouts in any of the three conditions. Participants in the therapist-delivered
CBT condition showed statistically significant improvements on the HRSD and BDI
from pre-treatment to post-treatment in comparison to individuals in the computerassisted CBT condition. The authors hypothesized that these between-group
differences may be accounted for by the lack of behavioral interventions in the
Overcoming

Depression

program or by non-specific therapeutic factors.
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Whitfield, Hinshelvvood, Pashely, Campsie, and Williams (2006) conducted a
subsequent study of a modified version of the Overcoming Depression

program,

which had more favorable results than those observed in the Bowers, et al. (1993)
study. Unlike the iteration of Overcoming

Depression

utilized in the Bowers, et al.

(1993) study, the version of the program tested by Whitfield and colleagues (2006)
included an emphasis on behavioral skills to combat maladaptive behaviors and
inactivity, in addition to other components included in the previous version of the
program. Whitfield, et al. (2006) offered computerized CBT to 78 individuals
referred to a mental health clinic for symptoms of depression and anxiety, while they
were on a four-month waitlist to receive clinical services. Of the 78 individuals who
were offered computerized CBT, 20 individuals attended at least one session of
computerized CBT and 14 individuals completed all six sessions of computerized
CBT. The computerized CBT treatment was offered in three locations: a clinical
psychology department, a university reading room, and a community health center
located within a shopping center. Participants who completed the computerized C B T
program were minimally assisted by a self-help support nurse over the course of
treatment. Treatment completers showed clinically and statistically significant
decreases on the BDI-II, with average scores decreasing f r o m the severe range to the
mild range. Treatment completers also showed decreases on the BAI, from the
moderate to severe range to the mild range. Furthermore, scores on the BDI-II and
BAI continued to decrease through follow-up.
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Of note, 72% of referred patients in the Whitfield, et al. (2006) study refused
computerized CBT services while on the waiting list to receive therapist-administered
services, suggesting that some aspect of computerized CBT is unappealing to
consumers seeking therapy services. To investigate attitudes toward computerized
CBT, Mitchell and Gordon (2007) conducted a two-stage study examining perceived
credibility, expectancy for improvement, likelihood of using computerized CBT,
preferences for therapy modalities, and perceived advantages and disadvantages of
computerized CBT. In the first stage of the study, 122 university students were given
a series of self-report measures about the aforementioned topics. These students rated
the perceived credibility of computerized CBT as a 12.20 out of 27 possible points,
the average expected improvement in symptoms as a result of using computerized
CBT as 34.7%, and the average likelihood of using a computerized CBT program as
47.6%, all of which were considered to be poor ratings. In the second stage of the
study, 20 students who were involved in the first stage of the study met with a
researcher and received a half-hour demonstration of the Overcoming

Depression

program. After receiving a demonstration of the computerized CBT program, median
credibility ratings increased from 13.50 to 20.50, median expectancy for
improvement increased from 40% to 60%, median likelihood of using computerized
CBT increased f r o m 40% to 80%, and preference for using computerized CBT
increased from 15% to 30%. These data suggest that favorable perceptions of
computerized C B T can be increased through relatively minimal intervention.
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The other well-known computerized CBT program for depression that has
emerged is Beating the Blues. Beating the Blues is an eight-session CBT program
that includes behavioral components, focusing on pleasant activity scheduling,
problem-solving, sleep hygiene, graded exposure, and breaking down tasks, as well as
cognitive components, including identifying and challenging thinking errors, negative
automatic thoughts, and maladaptive core beliefs. Proudfoot and colleagues initially
tested this program with 274 patients presenting in a primary care setting with
symptoms of depression and/or anxiety (Proudfoot, Ryden, Everitt, Shapiro,
Goldberg, Mann, et al., 2004). Patients were randomly assigned to computerized
CBT or treatment-as-usual. The treatment-as-usual condition was not controlled,
such that patients in this condition could receive any treatment recommended by their
general practitioner, as well as treatment that they opted to seek on their own.
Antidepressant use was allowed in both conditions. Dropout rates in the
computerized C B T condition were 35% for the first phase of the study and 22% for
the second phase of the study, which is comparable to rates reported for face-to-face
CBT. Patients in the computerized CBT condition demonstrated statistically
significant improvement on the measures of depression, negative attributional style,
and work and social adjustment. Furthermore, they also demonstrated improvements
in symptoms of anxiety that approached significance. These gains were maintained at
follow-up through six months.
Cavanagh, Shapiro, Van Den Berg, Swain, Barkham, and Proudfoot (2006)
conducted a subsequent naturalistic, non-randomized treatment outcome study of
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Beating the Blues.

T w o hundred and nineteen individuals presenting with depression

and/or anxiety at primary or secondary care settings were given the option to receive
computerized CBT. Of the 219 individuals who completed pre-treatment measures,
62% completed all eight sessions of the computerized C B T program and 47%
completed at least one post-treatment assessment. Statistically and clinically
significant improvements were observed among treatment completers and individuals
included in an intent-to-treat analysis on measures of self-reported depression, selfreported anxiety, work and social adjustment, and a broader measure of psychological
well-being. These improvements were maintained at six-month follow-up.
Clarke, Reid, Eubanks, O'Connor, DeBar, Kelleher, Lynch, et al. (2002) were
the first group of researchers to test a computerized treatment for depression
administered via the Internet with no clinician monitoring or assistance. The
Overcoming

Depression

on the Internet (ODIN) program is an Internet-based, self-

help program that focuses on cognitive techniques for treating depression, with a
focus on cognitive restructuring. The program was based on existing group
cognitive-behavioral therapy manuals and involved seven "chapters" that presented
cognitive techniques, as well as provided interactive examples, practice opportunities,
and feedback about improvement over time. Clarke, et al. (2002) recruited
participants for their study by sending brochures to 6,994 depressed adults and 6,996
nondepressed adults who were enrolled in a nonprofit HMO. T w o hundred and
twenty-three depressed individuals and 76 nondepressed individuals responded to the
brochure and were randomized to the experimental condition (n=144) or a no-access

control group (n=155). Mean intake scores on the CES-D indicated that participants
were in the severely depressed range at the beginning of the study. While enrolled in
the study, participants were allowed to seek any additional treatment-as-usual care for
their depression, as they deemed necessary. Participants were allowed to access the
ODIN program as many times as they desired over the course of the study. The CESD was administered at 4-, 8-, 16-, and 32-weeks after enrolling in the study.
Participants in the ODIN condition accessed the website infrequently, with a range of
one to 20 times accessed and a mean of 2.6 times accessed. No overall differences
were observed between experimental and control conditions over time, however posthoc analyses of individuals with low levels of depression at intake revealed a modest
effect at 16- and 32-week follow-ups. Clarke, et al. (2002) hypothesized that the lack
of main effects observed in this study may be accounted for by low usage of the
ODIN website and the severely depressed nature of individuals who enrolled in the
study.
A subsequent study of the ODIN program, conducted by Clarke, Eubanks,
Reid, Kelleher, O'Connor, DeBar, et al. (2005) revealed some positive effects for the
program. Six thousand and thirty individuals who had received either medication or
psychotherapy services for depression in the past thirty days and 6,021 individuals
who had not received any services for depression were recruited from a nonprofit
H M O through the use of mailed brochures. T w o hundred depressed individuals and
55 nondepressed individuals were randomized to one of three conditions: treatmentas-usual (n=100), ODIN with postcard reminders to use the website (n=75), and
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ODIN with telephone reminders to use the website (n=80). Reminders to access the
ODIN program were given in both treatment groups at 2-, 8-, and 13-weeks postenrollment and included similar content. Reminders to complete follow-up
assessments were e-mailed to all participants at 5-, 10-, and 16-weeks postenrollment. Both groups that received access to the ODIN program experienced
statistically and clinically significant improvements in comparison to the control
group on the CES-D. Additionally, those individuals who were more severely
depressed at intake experienced more significant decreases in depression, with an
effect size of 0.537 compared to 0.277 for the entire sample of individuals in the
experimental groups. The authors hypothesized that the significant findings observed
in this study could likely be accounted for by increases in accessing the ODIN
website, in comparison to their initial test of the ODIN website, which demonstrated
no positive effects of the program relative to the control group.
After the development of the ODIN program, another group of researchers
developed a different computerized treatment for depression called
Similar to ODIN, MoodGYM

MoodGYM.

is a self-help program administered via the Internet

without clinician assistance or monitoring. MoodGYM

is completed over six weekly

sessions and focuses on cognitive restructuring, pleasant activities, assertiveness
training, problem-solving, and relaxation strategies, with the sixth session reviewing
all of this material. An initial test of the efficacy of MoodGYM
Christensen, Griffiths, and Jorm (2004), in which MoodGYM

was conducted by
was compared to a

psychoeducational website about depression (BluePages) and an attention control
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condition. Participants assigned to the BluePages

were instructed to look at one

section of the website each week for five weeks, with the sixth week providing an
overview of the material covered. The website provided information about the
depression symptoms, diagnosis, interventions, and resources. Participants assigned
to the attention placebo condition spoke with an interviewer on a weekly basis about
lifestyle habits and environmental factors that might have a relationship to depression.
A recruitment questionnaire was sent to 27,000 people, 525 of which had elevated
symptoms of depression and were randomized to the BluePages
the MoodGYM

condition (n=166),

condition (n=182), or attention placebo (n=178). Twenty-five

participants assigned to BluePages,

46 participants assigned to MoodGYM,

and 19

participants assigned to the attention placebo condition dropped out prior to
completing their respective intervention. The difference in drop-out rates between the
MoodGYM

and BluePages

conditions was statistically significant. Pre-post effect

sizes using an intent-to-treat analysis were 0.4, 0.4, and 0.1 for
BluePages,

MoodGYM,

and the attention placebo. When examining data from completers only,

the effect sizes for MoodGYM

and BluePages

increased to 0.6 and 0.5, respectively,

and when examining data from completers with clinical depression as indicated by a
CES-D score of over 16, effect sizes were 0.9, 0.75, and 0.25 for
BluePages,

MoodGYM,

and attention placebo, respectively. In addition to reducing symptoms of

depression, MoodGYM

reduced dysfunctional thinking and increased knowledge of

effective psychological treatments. Similarly, BluePages

increased knowledge of

medical, psychological, and lifestyle treatments for depression. These data indicate
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that psychoeducation and cognitive-behavioral therapy provided through the Internet
are more effective at reducing symptoms of depression than placebo, with unique
additional effects observed for each active condition. Mackinnon, Griffiths, and
Christensen (2008) obtained six- and twelve-month follow-up data from participants
involved in this study. Participants in all three conditions continued to show modest
declines in symptoms of depression through twelve-month follow-up. At six-month
follow-up, only individuals assigned to the MoodGYM

maintained statistically

significant improvements in symptoms of depression, relative to controls, however at
twelve-months, both the MoodGYM

condition and the BluePages

condition

demonstrated statistically significant advantages relative to the attention placebo.
A subsequent investigation of the MoodGYM

program attempted to determine

whether all modules of the program were necessary to achieve observed treatment
effects (Christensen, Griffiths, Mackinnon, & Brittliffe, 2006). Two thousand seven
hundred and ninety-four participants recruited through the MoodGYM

website who

had elevated scores on the Goldberg Depression Scale were randomly assigned to one
of six versions of the MoodGYM

website: Version 1 (one session of brief CBT),

Version 2 (brief CBT plus problem-solving), Version 3 (brief CBT plus problemsolving and stress management techniques), Version 4 (extended CBT plus problemsolving), Version 5 (extended CBT plus problem-solving and behavioral techniques
for managing depression), and Version 6 (the full MoodGYM

program). Of note, only

20.4% of participants completed their assigned intervention. Data from these
participants suggested that Version 1 and Version 2 were not successful at reducing
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symptoms of depression and that Version 4 and Version 5 were most successful at
decreasing symptoms of depression, with Version 4 yielding the largest overall effect
size. These data suggest that the inclusion of the extended CBT component of the
MoodGYM

program is important to achieving optimal treatment effects. The authors

also commented on the dropout rate of the study and hypothesized that continuous
monitoring of participants, like the strategies applied in the in the Clarke, et al. (2005)
study, may minimize dropout and should be considered in future investigations.
In addition to the four programs mentioned previously, other programs exist
that utilize technology to address symptoms of depression, but do not fit the
description of a largely standalone computerized CBT intervention. Good Days
Ahead: The Multimedia

Program for Cognitive Therapy retains the multimedia

interactivity approach of the aforementioned computerized CBT programs, however
in both studies investigating its efficacy, patients had access to therapist-administered
psychotherapy services (Cavanagh & Shapiro, 2004; Wright, Wright, Albano, Basco,
Goldsmith, Raffield, et al., 2005). As with Good Days Ahead, Cope allows users to
receive therapist-administered psychotherapy services and uses a computerized phone
system, rather than a computerized multimedia package (Gega, Marks, & MataixCols, 2004). Finally, Andersson and colleagues (2005) created a self-help program
that consisted of digitized versions of textual self-help materials, focusing on
cognitive therapy and behavioral activation (e.g. Andersson, Bergstrom, Hollandare,
Carlbring, Kaldo, & Ekselius, 2005). Although their program included quizzes to
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check for comprehension, it lacked the interactivity necessary to consider it to be a
truly computerized CBT intervention.
T w o meta-analyses have examined the available literature on computerized
C B T programs for depression. Cavanagh and Shapiro (2004) conducted a small
meta-analysis using five available studies of computerized C B T programs and found
a large pre-post effect size of 1.38, suggesting that computerized CBT programs
perform superiorly in comparison to treatment-as-usual and waitlist controls. A
subsequent meta-analysis conducted by Spek and colleagues (2007) examined the
effects of internet-based CBT for depression and anxiety, rather than examining the
efficacy of computerized CBT programs administered in clinical settings, as were
summarized in the Cavanagh and Shapiro (2004) meta-analysis (Spek, Cuijpers,
Nykicek, Riper, Keyzer, & Pop, 2007). Although Spek and colleagues (2007)
examined twelve randomized controlled trials in their meta-analysis and found a
moderate to large effect size favoring internet-based CBT over controls, only five of
these randomized controlled trials were studies specifically targeting symptoms of
depression. When examining these studies separately, internet-based CBT for
depression yielded a small effect size between 0.27 and 0.32, depending on the
statistical methodology used. The authors hypothesized that the small effect size for
internet-based CBT for depression could be accounted for by lack of therapist support
and monitoring, which is perhaps supported by the contrast between their findings
and that of Cavanagh and Shapiro (2004).

Problem Statement.

The present study seeks to build on the extant literature

in two primary ways. The available body of research suggests that behavioral
activation is an efficacious treatment for depression and computerized cognitivebehavioral interventions are efficacious treatments for depression, but no study has
examined the efficacy of a computerized behavioral activation treatment for
depression. The present study aims to provide preliminary data about the efficacy of
such a program. Secondly, previous data regarding possible mechanisms of action of
behavioral activation is incredibly limited and has reached contradictory conclusions.
Computerized behavioral activation programs lend themselves nicely to examining
mechanism of action, as interventions received by each participant are uniform in
nature. The present study seeks to build on existing data about possible mechanisms
of action of behavioral activation.
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CHAPTER III
METHOD
Sample.

Nine participants experiencing symptoms of depression were

recruited from Kalamazoo, Portage, and surrounding areas in Southwestern Michigan
through the use of recruitment flyers, printed newspaper advertisements, newspaper
advertisements available through the Internet, contacts with support groups, and
recruitment speeches made at local colleges and universities.
All participants had a score of eighteen or higher on the Beck Depression
Inventory - II (BDI-II), in addition to either meeting criteria for a diagnosis of Major
Depressive Disorder or Dysthymic Disorder based on the results of a Structured
Clinical Interview for DSM-IV Axis I Disorders (SCID-I) or receiving a score of ten
or higher on the Revised Hamilton Rating Scale for Depression (RHRSD). The
SCID-I and the RHRSD were administered and scored by trained independent
assessors.
Participants were excluded from further participation in the study if they were
determined to meet criteria for bipolar disorder, psychotic disorder, active substance
abuse, mental retardation and/or dementia during the pretreatment assessment phase
of the study. Additionally, participants were excluded if they were receiving any type
of psychotherapy services for their depression or if they had recently begun treatment
with antidepressants and had been taking their antidepressants for less than eight
weeks.
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Setting.

All assessment and treatment sessions were conducted in private

laboratory rooms on the second floor of W o o d Hall, located on the campus of
Western Michigan University.
Treatment.

The treatment utilized in this study was a server-based computer

program, titled Building a Meaningful

Life Through Behavioral

Activation.

The

substantive content of the computer program was developed by psychologists at
Western Michigan University and relies heavily upon recent iterations of behavioral
activation. The foci of the initial six sessions include psychoeducation about
depression and the treatment of depression through the use of behavioral activation,
assignments that focus on tracking behaviors, information about how behaviors affect
mood, assignments pertaining to changing behaviors to reflect personal values, and
information about practicing behaviors such that they become routine. The remaining
four sessions consist of a series of mini-lessons that teach participants how to increase
adaptive activities, manage anger, apply for jobs, communicate more effectively with
others, engage in relaxation techniques, set and achieve goals, break down large tasks,
and achieve more routine and restful sleep patterns. For purposes of this study, all
participants received all mini-lessons, regardless of the extent to which information
covered in the mini-lessons applied to their specific problem. All sessions were
monitored by a computerized treatment administrator, all of whom were graduate
students in Clinical Psychology or Counselor Education and Counseling Psychology
programs at Western Michigan University. At the beginning of each session, the
computerized treatment administrator gave each participant a BDI-II, the Behavioral
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Activation for Depression Scale (BADS), and the Automatic Thoughts Questionnaire
(ATQ). After completing these measures, the computerized treatment administrator
oriented the participant to the computer and asked if he or she had any questions prior
to beginning the session. The computerized treatment administrator then answered
any questions the participant had and allowed the participant to complete the session
on his or her own. The average session length across participants and sessions was 52
minutes, with a range of 18 minutes to 100 minutes. At the end of the session, the
computerized treatment administrator reviewed the session with the participant,
reminded the participant to complete his or her homework, and allowed the
participant to ask clarifying questions regarding the material contained in the
program. The average amount of time the computerized treatment administrators
spent with participants across sessions was eight minutes, with a range of two minutes
to 30 minutes.
Measures.

Symptoms of depression and related constructs were tracked

throughout the present study through the use of a variety of measures. The Beck
Depression Inventory - II (BDI-II; Beck, Steer, & Brown, 1996; Appendix A) is one
of the most widely used self-report measures of depression. The BDI-II was
administered to participants during both pretreatment assessments, prior to each
treatment session, and at all post-treatment assessments. The BDI-II is a 21-item
measure that assesses for symptoms of depression, comparable to the symptoms
described in the DSM-IV-TR diagnostic criteria for Major Depressive Disorder. Each
item of the BDI-II is rated on a four-point Likert-type scale, ranging from zero to

three. The items are then summed to yield a total score, with scores between zero and
13 suggesting minimal levels of depression, 14 to 19 suggesting mild levels of
depression, 20 to 28 suggesting moderate levels of depression, and 29 to 63
suggesting severe levels of depression. The BDI-II has demonstrated acceptable
reliability and validity and demonstrates moderately high correlations with the
Revised Hamilton Psychiatric Rating Scale for Depression, the Beck Hopelessness
Scale, and the SCL-90-R Depression subscale (Beck, Steer, & Brown, 1996; Steer,
Ball, Ranieri, & Beck, 1997).
The Revised Hamilton Rating Scale for Depression (RHRSD; Warren, 1994;
Appendix B) is a clinician-rated scale, intended to be completed after a clinical
interview, that provides a quantitative measure of the clinician's assessment of a
patient's level of symptoms of depression and the impact of these symptoms on the
patient's everyday functioning. The R H R S D was completed by the independent
assessors involved in the present study after the second pretreatment assessment and
after each post-treatment assessment. The R H R S D consists of 22 items, 17 of which
may be scored. Nine of these items are rated on a five-point scale, from zero to four,
and eight of these items are rated on a three-point scale, from zero to two. These
scores are then summed to yield a total score. Scores below six suggest that the
individual is in the nondepressed range, scores between seven and 17 suggest the
individual is experiencing mild levels of depression, scores between 18 and 24
suggest the individual is experiencing moderate levels of depression, and scores
above 25 suggest the individual is experiencing severe levels of depression. The
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R H R S D displays adequate reliability and has a mean correlation of .67 with a wide
variety of other measures of symptoms of depression, which demonstrates acceptable
concurrent validity (Burnett, 1998).
The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I;
First, Gibbon, Spitzer, & Williams, 1996; Appendix C) is a semi-structured interview
used to diagnose major DSM-IV disorders. The SCID-I was administered by the
independent assessors involved in the present study during the second pretreatment
assessment and during each post-treatment assessment. The SCID-I consists of six
major modules, including Mood Episodes, Psychotic Symptoms, Psychotic Disorders,
Mood Disorders, Substance Use Disorders, and Anxiety and Other Disorders. The
reliability of the SCID has been adequately demonstrated (Segal, Hersen, & Van
Hasselt, 1994), however little data exists on its validity.
The Behavioral Activation for Depression Scale (BADS; Kanter, Mulick,
Busch, Berlin, & Martell, 2006; Appendix D) is a self-report measure that examines
changes in client behavior over the course of behavioral activation therapy. The
BADS was administered to participants during the second pretreatment assessment,
prior to each treatment session, and at all post-treatment assessments. The BADS is a
25-item measure that consists of four subscales (Activation, Avoidance/Rumination,
Work/School Impairment, and Social Impairment), although for purposes of the
present study, only the Activation and Avoidance/Rumination subscales were used.
Each item of the BADS is rated on a seven-point Likert-type scale, ranging from zero
to six. Subscale items are then summed, with higher scores indicating greater levels
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of the construct measured. The BADS demonstrates acceptable test-retest reliability
(Kanter, et al., 2006) and construct validity through expected significant correlations
with the BDI, CBAS, and SSQ (Kanter, et al., 2006; Kanter, Rusch, Busch, & Sedivy,
2009).
The Automatic Thoughts Questionnaire (ATQ; Hollon & Kendall, 1980;
Appendix E) is a self-report measure that assesses the frequency of common negative
automatic thoughts over the course of the previous week. The ATQ was administered
to participants as part of the second pretreatment assessment, prior to each treatment
session, and as part of all post-treatment assessments. The ATQ consists of 30 items,
for which participants are asked to use a five-point, Likert-type scale ranging from
one to five to rate frequency of negative automatic thoughts. These items are then
summed to yield a total score, with higher scores indicating more frequent
occurrences of negative automatic thoughts. The ATQ demonstrates high internal
reliability and a strong correlation with therapist ratings of depression and commonly
utilized self-report measures of depression (e.g. BDI) (Dobson & Breiter, 1983;
Harrell & Ryon, 1983). Furthermore, the A T Q demonstrates a strong negative
correlation with the BADS (Kanter, et al., 2006).
The Quality of Life Scale (QOLS; Flanagan, 1978; Appendix F) is a selfreport measure assessing six areas related to quality of life: Material and Physical
Well-Being; Relationships with Other People; Social, Community, and Civic
Activities; Personal Development and Fulfillment; Recreation; and Independence
(Burckhardt & Anderson, 2003). The QOLS was administered to participants as part

of the second pretreatment assessment and during each post-treatment assessment.
The QOLS consists of 16 items, each rated on a seven-point, Likert-type scale
ranging from one to seven. These items are then summed to yield a total score, with
higher total scores suggesting higher quality of life. Studies of the psychometric
properties of the QOLS suggest that it demonstrates adequate reliability and validity
(Burckhardt & Anderson, 2003).
In addition to the standardized outcome measures used in the present study, a
number of idiographic measures were utilized to gather demographic information,
measure treatment outcome, and assess consumer satisfaction. The Initial
Assessment Information Form (Appendix G) was administered to participants during
the first pretreatment assessment appointment. This form gathered basic
demographic data (e.g. age, race, sex), information about previous and current
treatments for depression, and self-report ratings of experience and comfort with
computer use. The Additional Services Form (Appendix H) was administered to
participants as part of each post-treatment assessment appointment. This form asked
participants to report any mental health services they have received since the
completion of the treatment phase of the study. In addition to these measures, the
Valued Living Questionnaire, a measure of homework completion, and measures of
consumer satisfaction were embedded within the Building a Meaning/id
Behavioral

Activation

Procedure.

Life

Through

program.

Adult participants experiencing symptoms of depression were

recruited for the present study through the use of posted flyers, newspaper
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advertisements, contacts with support groups, and contacts with agencies providing
mental health services. Prospective participants called the Anxiety Disorders
Laboratory telephone and left messages requesting to be contacted with further
information regarding the present study. A research assistant returned the telephone
calls of prospective participants and utilized a phone script (Appendix I) to describe
the research study to prospective participants. Prospective participants who indicated
interest in participating in the present study were given the opportunity to schedule
initial screening assessments, which were scheduled at the end of the initial
aforementioned phone contacts.
Upon arrival for their initial screening appointments, prospective participants
were greeted by a research assistant and led in to a private laboratory room. Once in
the laboratory room, a research assistant provided prospective participants with two
copies of the informed consent document (Appendix J) and read this document aloud
to the prospective participants. Prospective participants were asked if they had any
questions, which were answered by the research assistant. Prospective participants
were then asked to sign both copies of the consent forms, one of which was retained
in the participant's file in the laboratory of the researcher and one of which was given
to participants to keep in their own personal records. After signing the informed
consent documents, participants were asked to complete an Initial Assessment
Information Form and a BDI-II form. Participants were then asked to return one
week later to complete a comprehensive second assessment.
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At the comprehensive second assessment appointment, participants were
greeted by an independent assessor and asked to complete a BDI-II form.
Participants with a score of 18 or higher on the BDI-II then completed a SCID-I with
the independent assessor, who then also completed a R H R S D after the interviews
with participants. Participants who were eligible for inclusion in the study on the
basis of these three measures were then asked to complete the BADS, the ATQ, and
the QOLS.

Ineligible participants were provided with referral information for local

mental health providers.
Those participants who were eligible for inclusion on the basis of their
comprehensive second assessment results were asked to return to the laboratory one
week later to begin treatment. Participants attended ten weekly sessions of
computerized behavioral activation therapy. At the beginning of each session,
participants were greeted by a computerized treatment administrator. All the
computerized treatment administrators were graduate students in either the Clinical
Psychology or Counselor Education and Counseling Psychology programs at Western
Michigan University. The computerized treatment administrator led participants to a
private laboratory room, where the computer was located, and asked the participants
to complete a BDI-II, BADS, and ATQ. The computerized treatment administrator
monitored suicidality through the BDI-II and handled elevated suicide risk according
to a predetermined protocol. After completing these measures, participants were
asked if they had any questions about the program, previous material covered in the
program, or homework assignments from the previous session. Questions were
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answered by the computerized treatment administrators to the best of their ability.
Participants were then left alone in the laboratory room to complete their session of
computerized behavioral activation therapy. After completing their session,
participants notified the computerized treatment administrator, who then reviewed the
content of the session with them and provided them with a session summary sheet.
Participants were asked if they had any questions regarding their session and these
questions were answered by the computerized treatment administrator. Participants
were then reminded to complete their homework and a session for the following week
was scheduled.
After ten weeks of treatment, participants were asked to return to the clinic
one week later to complete a post-treatment follow-up assessment. This appointment
was similar to the comprehensive second assessment, as participants completed a
BDI-II, the BADS, the ATQ, and the QOLS. Additionally, a SCID-I interview was
conducted and the RHRSD was completed by an independent assessor after the
interview. At this post-treatment assessment appointment, participants also
completed a Consumer Satisfaction Survey and an Additional Services Form.
Participants were then asked to attend a one-month follow-up assessment
appointment, during which they completed all aforementioned measures, except for
the Consumer Satisfaction Survey. Participants were also asked to attend follow-up
appointments at three-months and six-months post-treatment.
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CHAPTER IV
RESULTS

Analysis Plan. This investigation included a number of hypotheses regarding
depressive symptoms and mechanisms of action. First, it was hypothesized that
depressive symptoms would decrease from pretreatment to posttreatment and
continue to remain decreased through six-month follow-up, as measured by the BDIII and RHRSD. In order to test this hypothesis, a series of last observation carryforward (LOCF) one-way repeated measures analysis of variance (ANOVA) were
conducted.
Second, it was hypothesized that quality of life would increase from
pretreatment to posttreatment and continue to remain improved through six-month
follow-up, as measured by the QOLS. This hypothesis was also tested using a LOCF,
one-way repeated measures ANOVA.
Third, it was hypothesized that values-consistent behavior would increase
over the course of treatment, as measured by the VLQ. As with the prior two
hypotheses, this hypothesis was tested using a LOCF, one-way repeated measures
ANOVA.
Fourth, it was hypothesized that homework completion would be positively
correlated with decreases in BDI-II scores. In order to test this hypothesis, a Pearson
Product-Moment Correlation was conducted.
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Finally, it was hypothesized that changes in the patterns and nature of overt
behavior of participants would be the primary mechanism by which treatment effects
would be observed. This hypothesis was tested in a variety of ways. First, a series of
LOCF, one-way repeated measures ANOVAs were conducted using data obtained
from the ATQ, BADS, and VLQ. Second, a series of Pearson Product-Moment
Correlations were conducted between these data and the BDI-II. Finally, all data
from these measures and the BDI-II were plotted on a graph for visual inspection.
Of note, participant number eight was identified as the only participant who
became worse over the course of treatment, as measured by an increase in BDI-II
scores from 29 at pretreatment to 44 at six-month follow-up. Thus, participant
number eight was considered to be a distinct nonresponder to treatment and as such,
two analyses were conducted for each outcome measure: one including the data of
participant number eight and one excluding the data of participant number eight.
These data are identified accordingly in the data analyses below.
In addition to conducting statistical analyses of aggregated data, visual
inspection of individual participant graphs was also a component of the analysis plan.
The decision to examine individual participant data was made on the based on two
primary issues. First, given the low sample size, relying solely on statistical analysis
in this instance may obfuscate significant changes on an individual participant level
that occurred over the course of treatment. Second, conducting an idiographic
analysis allowed for greater capacity to investigate the role of mediational variables in
treatment.
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Preliminary

Analyses.

Forty-three potential participants contacted the

Anxiety Disorders Laboratory to learn more information about the present study. Of
these individuals, fifteen potential participants attended at least one of the two
pretreatment assessment appointments and nine individuals were enrolled in
treatment. Of the six potential participants who were not enrolled in treatment, four
potential participants did not qualify on the basis of BDI-II cutoff scores, one
potential participant self-excluded on the basis of an exclusionary diagnosis, and one
participant did not return to complete a second comprehensive assessment
appointment. The nine individuals who participated in the study all completed the
minimum five sessions of computerized behavioral activation therapy required to be
considered treatment completers, although two individuals terminated treatment after
session five, one individual terminated treatment after session six, and one individual
terminated treatment after session eight. One of the individuals who terminated after
session five did so due to frustration with program functionality and the other
individual who terminated after session five did so due to difficulties with scheduling.
The other two individuals who prematurely terminated did so due to returning home
after the Spring semester for summer recess.
Demographic data for the nine treatment completers is displayed in Table 1.
Of the nine participants who completed the study, two participants (22.2%) were male
and seven participants (77.8%) were female. The mean age of participants was 34.9
years of age, with a range of 18 years of age to 60 years of age. Eight participants
(88.9%) were Caucasian and one participant (11.1%) was Multiracial. In terms of

marital status, seven participants (77.8%) were single, one participant (11.1%) was
separated, and one participant (11.1%) was divorced or annulled. Two participants
(22.2%) were currently employed, six participants (66.7%) were unemployed, and
one participant (11.1%) was a student. Seven participants (77.8%) had completed
some college and two participants (22.2%) had graduated from a two-year college or
technical school. The socioeconomic status of participants varied widely, with three
participants (33.3%) making under $5,000 annually, one participant (11.1%)
participant making $5,000 to $9,999 annually, one participant (11.1%) making
$10,000 to $14,999 annually, two participants (22.2%) making $15,000 to $24,999
annually, and one participant (11.1%) making $25,000 to $34,999 annually.
Furthermore, one participant (11.1%) failed to report socioeconomic data.
Information regarding previous and current treatments for depression was also
gathered for all participants. T w o participants (22.2%) reported no prior treatments
for their symptoms of depression. Four participants (44.4%) reported receiving
medications, five participants (55.6%) reported participating in individual therapy,
one participant (11.1%) reported participating in a support group, one participant
(11.1%) reported receiving pastoral care, one participant (11.1%) reported being
hospitalized, and one participant (11.1%) reported receiving an unlisted treatment for
depression. In terms of current treatments for depression, seven participants (77.8%)
reported that they were not currently receiving any treatment for their symptoms of
depression. One participant (11.1%) reported receiving an unlisted treatment for

45
depression and one participant (11.1%) failed to report current treatments for
depression.
Finally, participants were asked to report information regarding their
computer use habits. Participants reported an average of 13.4 years of experience
with computers and reported using computers for an average of 15.2 hours a week.
Using a Likert-type scale ranging from one to ten, with "one" representing
"completely uncomfortable" and "ten" representing "completely comfortable,"
participants reported an average rating of 8.3, suggesting a high level of comfort with
computers. Participants also asked to report their perceived amount of knowledge
about computers. Using this same type of scale, with "one" representing "no
knowledge" and "ten" representing "extensive knowledge," participants reported an
average rating of 7.1, suggesting a relatively extensive knowledge of computers.
Table 1
Demographic Variables for Full Sample, Non-Qualifiers, and Completers
Variable

Full Sample
(n=15)
37.1
18-60

Non-Qualifiers
(n=6)
40.5
19-57

Completers
(n=9)
34.9
18-60

Race
Caucasian/White
African-American
Multiracial

11 (73.3%)
2(13.3%)
2 (13.3%)

3 (50.0%)
2 (33.3%)
1 (16.7%)

8 (88.9%)
0 (0.0%)
1 (11.1%)

Sex
Male
Female

7 (46.7%)
8 (53.3%)

5 (83.3%)
1 (16.7%)

2 (22.2%)
7 (77.8%)

Age (Mean)
Age (Range)

Table 1 (Continued)
Marital Status
Single
Married
Separated
Divorced or Annulled

11 (73.3%)
2(13.3%)
1 (6.7%)
1 (6.7%)

4 (66.7%)
2 (33.3%)
0 (0.0%)
0 (0.0%)

7 (77.8%)
0 (0.0%)
1 (11.1%)
1 (11.1%)

Occupational Status
Currently Employed
Unemployed
On Disability
Stay at Home Parent
Student

4 (26.7%)
8 (53.3%)
1 (6.7%)
1 (6.7%)
1 (6.7%)

2 (33.3%)
2 (33.3%)
1 (16.7%)
1 (16.7%)
0 (0.0%)

2 (22.2%)
6 (66.7%)
0 (0.0%)
0 (0.0%)
1 (11.1%)

4 (26.7%)
2 (13.3%)
3 (20.0%)
2 (13.3%)
1 (6.7%)
0 (0.0%)
1 (6.7%)
1 (6.7%)
1 (6.7%)

1 (16.7%)
1 (16.7%)
2 (33.3%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
1 (16.7%)
1 (16.7%)
0 (0.0%)

3 (33.3%)
1 (11.1%)
1 (11.1%)
2 (22.2%)
1 (11.1%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
1 (11.1%)

9 (60.0%)
4 (26.7%)

2 (33.3%)
2 (33.3%)

7 (77.8%)
2 (22.2%)

1 (6.7%)
1 (6.7%)

1 (16.7%)
1 (16.7%)

0 (0.0%)
0 (0.0%)

4 (26.7%)
8 (53.3%)
7 (46.7%)
1 (6.7%)
2 (13.3%)
1 (6.7%)
1 (6.7%)
2 (13.3%)
2 (13.3%)

2 (33.3%)
4 (66.7%)
2 (33.3%)
1 (16.7%)
1 (16.7%)
1 (16.7%)
0(0.0%)
1 (16.7%)
1 (16.7%)

2 (22.2%)
4 (44.4%)

Socioeconomic Status
Under $5,000
$5,000-$9,999
$10,000-$ 14,999
$15,000-$24,999
$25,000-$34,999
$35,000-$49,999
$50,000-$74,999
$75,000-$99,999
Unreported
Education Level
Some College
Graduated 2-Year
College / Tech. School
Graduated 4-Year College
Some Graduate School
Previous Treatments
None
Medications
Individual Therapy
Group Therapy
Support Group
Case Management
Pastoral Care
Hospital
Other

5 (55.6%)
0 (0.0%)
1 (11.1%)
0 (0.0%)
1 (11.1%)
1 (11.1%)
1 (11.1%)
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Table 3 (Continued)
Variable
Number of Previous
Treatments (Range)
Number of Previous
Treatments (Mean)
Current Treatments
None
Medications
SSRI
TCA
MAOI
SSNRI
Atypical
Antipsychotic
Mood Stabilizer
Anxiolytic
Weeks Taking
Medication (Mean)
Individual Therapy
Group Therapy
Support Group
Case Management
Pastoral Care
Hospital
Other
Unreported
Number of Current
Treatments (Range)
Number of Current
Treatments (Mean)
Years Experience With a
Computer (Mean)
Degree of Comfort With a
Computer (Mean)
Amount of Knowledge
About Computers (Mean)
Mean Number of Hours of
Weekly Computer Use
(Mean)

Full Sample
(n=15)
0-5

Non-Qualifiers
(n=6)
0-5

Completers
(n=9)
0-4

1.6

1.8

1.4

9 (60.0%)
4 (26.7%)
2 (13.3%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
1 (6.7%)
0 (0.0%)
2 (13.3%)
0 (0.0%)
211

2 (33.3%)
4 (66.7%)
2 (33.3%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
1 (16.7%)
0 (0.0%)
2 (33.3%)
0 (0.0%)
211

7 (77.8%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
N/A

2 (13.3%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
2 (13.3%)
1 (6.7%)
0-3

2 (33.3%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
1 (16.7%)
0 (0.0%)
0-3

0
0
0
0
0
0
1
1

0.5

1.2

0.1

12.4

10.8

13.4

8.3/10

8.2/10

8.3/10

7/10

6.8/10

7.1/10

15.9

16.8

15.2

(0.0%)
(0.0%)
(0.0%)
(0.0%)
(0.0%)
(0.0%)
(11.1%)
(11.1%)
0-1
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Hypothesis

Number One. As stated previously, it was hypothesized that

depressive symptoms would decrease from pretreatment to posttreatment and
continue to remain decreased through six-month follow-up. The means and standard
deviations for data obtained from the BDI-II are presented in Table 2. A LOCF, oneway repeated measures A N O V A was conducted to compare scores on the BDI-II at
Time 1 (pretreatment), Time 2 (posttreatment), and Time 3 (six-month follow-up) for
all treatment completers. There was a marginally significant effect for time, Wilks'
Lambda = .439, F (2, 7) = 4.467, p = .056, multivariate partial eta squared = .561.
These data suggest a trend toward decreases in symptoms of depression over time.
This statistical analysis was then repeated, excluding the data of participant number
eight, who was considered to be a nonresponder. The removal of the data of
participant number eight resulted in a significant effect for time, Wilks' Lambda =
.152, F (2, 6) = 16.680, p = .004, multivariate partial eta squared = .848. These data
suggest a very large effect size for improvement on BDI-II scores over time. These
statistical analyses were also conducted for percent change on the BDI-II. The results
of a LOCF, one-way repeated measures A N O V A conducted utilizing the full sample
suggested that there was not a significant effect for time, Wilks' Lambda = .595, F (2,
7) = 2.385, p = .162, multivariate partial eta squared = .405. These data suggest that
no significant effects were observed in terms of percent change on BDI-II scores.
This analysis was then repeated after excluding the data from participant number
eight. This analysis yielded a significant effect for time, Wilks' Lambda = .086, F (2,
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6) = 31.766, p = .001, multivariate partial eta squared = .914. These data suggest a
very large effect size for percent change in BDI-II scores over time.
Examining the data available at an individual participant level supports the
conclusion that substantial changes occurred in BDI-II scores between pretreatment,
posttreatment and follow-up (please reference Appendix K for individual participant
graphs). On the basis of BDI-II scores, four participants met criteria to be considered
full responders, defined as individuals with BDI-II scores below 13.

Furthermore,

three participants met criteria to be considered partial responders, defined as
individuals with BDI-II scores lower than the study inclusion criteria of 18, but higher
than the remission criteria of 13. The remaining two participants were considered to
be nonresponders. These response rates are comparable to those found in other
studies of the efficacy of behavioral activation, suggesting that the Building a
Meaningful

Life Through Behavioral

Activation

program performs as well as

expected in terms of treatment responder rates.
Table 2
Pretreatment, Posttreatment, and Six-Month Follow-Up Means and Standard
Deviations for BDI-II Scores and Percent Change
Time Period
Time 1 (Pretreatment Score) (Including
Nonresponder)

N
9

Mean
30.11

Standard Deviation
5.35

Time 2 (Posttreatment Score) (Including
Nonresponder)
Time 3 (Six-Month Follow-Up Score)
(Including Nonresponder)

9

16.22

13.22

9

15.11

12.83
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Table 3 (Continued)
Time 1 (Pretreatment Score) (Excluding
Nonresponder)
Time 2 (Posttreatment Score) (Excluding
Nonresponder)
Time 3 (Six-Month Follow-Up Score)
(Excluding Nonresponder)

8

30.25

5.70

8

13.5

11.11

8

11.5

7.35

Time 1 (Pretreatment Percent Change)
(Including Nonresponder)
Time 2 (Posttreatment Percent Change)
(Including Nonresponder)
Time 3 (Six-Month Follow-Up Percent
Change) (Including Nonresponder)

9

0

0

9

-40.41%

52.86

9

-43.10%

57.11

Time 1 (Pretreatment Percent Change)
(Excluding Nonresponder)
Time 2 (Posttreatment Percent Change)
(Excluding Nonresponder)
Time 3 (Six-Month Follow-Up Percent
Change) (Excluding Nonresponder)

8

0

0

8

-54.55

33.71

8

-60.99

20.88

Comparable analyses to those used with the BDI-II were then conducted with
the RHRSD. The means and standard deviations for data obtained from the RHRSD
are presented in Table 3. A LOCF, one-way repeated measures A N O V A was
conducted to compare scores on the RHRSD at Time 1 (pretreatment), Time 2
(posttreatment), and Time 3 (six-month follow-up) for all treatment completers. The
effect for time was not significant, Wilks' Lambda = .568, F (2, 7) = 2.659, p = .138,
multivariate partial eta squared = .432. These data suggest that RHRSD scores did
not improve significantly over time. This statistical analysis was then repeated,
excluding the data of participant number eight. This analysis yielded a marginally
significant effect for time, Wilks' Lambda = .395, F (2, 6) = 4.600, p = .061,
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multivariate partial eta squared = .605. These data suggest a non-significant trend
toward improvement of symptoms of depression, as measured by the RHRSD, over
time.
When examining the data of individual participants, numerous participants
met full responder or partial responder criteria. Of those individuals who met full
responder criteria on the basis of BDI-II scores, all but one participant also met full
responder criteria (a score of seven or below) on the basis of RHRSD scores.
Furthermore, the participant who did not meet full responder criteria also did not have
available follow-up data, so RHRSD scores had been carried forward from
pretreatment. Additionally, of the three individuals who were deemed to be partial
responders on the basis of BDI-II scores, one individual met criteria to be considered
a full responder on the basis of R H R S D scores. Furthermore, the other two
participants who were partial responders did not have available follow-up data, so
their pretreatment RHRSD scores were carried forward as well.
Table 3
Pretreatment, Posttreatment, and Six-Month Follow-Up Means and Standard
Deviations for R H R S D Scores
Time Period
Time 1 (Pretreatment Score) (Including
Nonresponder)

N
9

Mean
13.56

Standard Deviation
3.57

Time 2 (Posttreatment Score) (Including
Nonresponder)
Time 3 (Six-Month Follow-Up Score)
(Including Nonresponder)

9

8.44

5.15

9

7.67

5.76
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Table 3 (Continued)
Time 1 (Pretreatment Score) (Excluding
Nonresponder)
Time 2 (Posttreatment Score) (Excluding
Nonresponder)
Time 3 (Six-Month Follow-Up Score)
(Excluding Nonresponder)

Hypothesis

8

13.75

3.77

8

7.88

5.19

8

6.38

4.57

Number Two. The second hypothesis tested in the present

investigation was that perceived quality of life would increase from pretreatment to
posttreatment and remain at an increased level through six-month follow-up. The
means and standard deviations for data obtained from the QOLS are presented in
Table 4. A LOCF, one-way repeated measures ANOVA was conducted to compare
scores on the QOLS at Time 1 (pretreatment), Time 2 (posttreatment), and Time 3
(six-month follow-up) for all treatment completers. The effect for time was not
significant, Wilks' Lambda = .730, F (2, 7) = 1.292, p = .333, multivariate partial eta
squared = .270. These data suggest that QOLS scores did not increase significantly
over time. This statistical analysis was then repeated without the data of participant
number eight included. The results remained non-significant, Wilks' Lambda = .726,
F (2, 6) = 1.135, p = .382, multivariate partial eta squared = .274, suggesting that
quality of life did not improve over the course of treatment and follow-up. These
findings were corroborated by examining individual participant graphs, as only full
responder #1 and full responder #3 appeared to have sustained increases in overall
quality of life (please reference Appendix L for individual participant graphs).
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Table 4 (Continued)
Pretreatment, Posttreatment, and Six-Month Follow-Up Means and Standard
Deviations for QOLS Scores
Time Period
Time 1 (Pretreatment Total Score) (Including
Nonresponder)

N
9

Mean
55.78

Standard Deviation
10.87

Time 2 (Posttreatment Total Score) (Including
Nonresponder)
Time 3 (Six-Month Follow-Up Total Score)
(Including Nonresponder)

9

62.78

20.49

9

59.33

17.36

Time 1 (Pretreatment Total Score) (Excluding
Nonresponder)

8

57.75

9.75

Time 2 (Posttreatment Total Score) (Excluding
Nonresponder)
Time 3 (Six-Month Follow-Up Total Score)
(Excluding Nonresponder)

8

64.75

20.97

8

60.88

17.88

Time 1 (Pretreatment Relationships and Material
Well-Being Score) (Including Nonresponder)
Time 2 (Posttreatment Relationships and Material
Well-Being Score) (Including Nonresponder)
Time 3 (Six-Month Follow-Up Relationships and
Material Well-Being Score) (Including
Nonresponder)

9

21.89

4.31

9

26.00

8.26

9

24.89

6.72

Time 1 (Pretreatment Relationships and Material
Well-Being Score) (Excluding Nonresponder)
Time 2 (Posttreatment Relationships and Material
Well-Being Score) (Excluding Nonresponder)

8

22.63

3.96

8

26.75

8.50
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Table 4 (Continued)
Time 3 (Six-Month Follow-Up Relationships and
Material Weil-Being Score) (Excluding
Nonresponder)
Time 1 (Pretreatment Health and Functioning
Score) (Including Nonresponder)
Time 2 (Posttreatment Health and Functioning
Score) (Including Nonresponder)
Time 3 (Six-Month Follow-Up Health and
Functioning Score) (Including Nonresponder)

8

25.38

7.01

9

14.33

3.12

9

15.11

5.01

9

16.67

5.68

Time 1 (Pretreatment Health and Functioning
Score) (Excluding Nonresponder)
Time 2 (Posttreatment Health and Functioning
Score) (Excluding Nonresponder)
Time 3 (Six-Month Follow-Up Health and
Functioning Score) (Excluding Nonresponder)

8

14.38

3.34

8

15.50

5.21

8

17.00

5.98

Time 1 (Pretreatment Personal, Social, and
Community Commitment Score) (Including
Nonresponder)
Time 2 (Posttreatment Personal, Social, and
Community Commitment Score) (Including
Nonresponder)
Time 3 (Six-Month Follow-Up Personal, Social,
and Community Commitment Score) (Including
Nonresponder)

9

20.00

7.02

9

22.78

8.17

9

21.11

7.54

Time 1 (Pretreatment Personal, Social, and
Community Commitment Score) (Excluding
Nonresponder)
Time 2 (Posttreatment Personal, Social, and
Community Commitment Score) (Excluding
Nonresponder)
Time 3 (Six-Month Follow-Up Personal, Social,
and Community Commitment Score) (Excluding
Nonresponder)

8

21.25

6.34

8

23.75

8.15

8

22.25

7.19

As expected based on the data presented here, the results of LOCF, one-way
repeated measures ANOVAs conducted with the three subscales of the QOLS

(Relationships and Material Well-Being; Health and Functioning; Personal, Social,
and Community Commitment) were also non-significant. The means and standard
deviations for these data are also presented in Table 4.
Hypothesis

Number Three. As stated previously, it was hypothesized that

values-consistent behavior would increase over the course of treatment. The means
and standard deviations for data obtained f r o m the V L Q are presented in Table 5. A
LOCF, one-way repeated measures A N O V A was conducted to compare scores on the
V L Q at Time 1 (session three of treatment), Time 2 (session six of treatment), and
Time 3 (session ten of treatment) for all treatment completers. The effect for time
was non-significant, Wilks' Lambda = .585, F (2, 7) = 2.485, p = .153, multivariate
partial eta squared = .415. These data suggest that values-consistent behaviors did
not increase significantly over the course of treatment. This statistical analysis was
then repeated, excluding the data from participant number eight. The removal of this
data resulted in a significant effect for time, Wilks' Lambda = .343, F (2, 6) = 5.740,
p = .040, multivariate partial eta squared = .657. These data suggest a very large
effect size for increases in values-consistent behavior over the course of treatment.
These data appear to be supported by a visual inspection of individual participant
graphs, as full responders #1, #2, and #3, and partial responder #2 all demonstrated
fairly sizeable increases in V L Q scores (please reference Appendix M for individual
participant graphs).
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Table4(Continued)
Session Three, Session Six, and Session Ten Means and Standard Deviations for
V L Q Scores

Time 1 (Session
Nonresponder)
Time 2 (Session
Nonresponder)
Time 3 (Session
Nonresponder)
Time 1 (Session
Nonresponder)
Time 2 (Session
Nonresponder)
Time 3 (Session
Nonresponder)

Time Period
Three Score) (Including

N
9

Mean
4.63

Standard Deviation
1.07

Six Score) (Including

9

5.82

2.01

Ten Score) (Including

9

5.82

2.16

Three Score) (Excluding

8

4.61

1.14

Six Score) (Excluding

8

6.16

1.85

Ten Score) (Excluding

8

6.10

2.12

Hypothesis

Number Four. The fourth hypothesis tested in the present study

was that homework completion would be positively correlated with decreases in BDIII scores. Average homework completion scores were computed by first assigning a
value to each of the responses. "None" was assigned a value of "1," "Some" was
assigned a value of "2," and "All" was assigned a value of "3." The scores for each
participant were then summed and divided by the number of sessions for which
homework completion scores were available. A Pearson Product-Moment
Correlation was then conducted to examine the relationship between homework
completion and change in BDI-II scores f r o m pretreatment to posttreatment. A nonsignificant, negative correlation between the two variables was observed, r - -.391,
n - 9 , p = .298. These data suggest that there is no relationship between homework
completion and changes in symptoms of depression. However, visual inspection of a
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scatterplot of change in BDI-II scores from pretreatment to posttreatment and average
homework completion scores revealed that those individuals who had the greatest
decreases in BDI-II scores also tended to have the highest average homework
completion scores. As such, it is possible that the statistical analysis of aggregated
data does not accurately represent the relationship between homework completion
and treatment outcome.
Scatterplot of Change in BDI-II Scores From Pretreatment
to Posttreatment and Average Homework Completion
Scores
3.5

0 -I
-40

;

,

-30

-20

1

,

,

-10

0

10

20

Change in BDI-II Scores

Figure 1. Scatterplot of Change in BDI-II Scores From Pretreatment to Posttreatment
and Average Homework Completion Scores
Hypothesis

Number Five. Finally, it was hypothesized that changes in the

patterns and nature of overt behavior of participants would be the primary mechanism
by which treatment effects would be observed. This hypothesis was first tested
through conducting a series of LOCF, one-way repeated measures A N O V A s were
conducted using data obtained from the ATQ, BADS, and VLQ (results reported in

hypothesis number three section). The means and standard deviations from data
obtained f r o m the A T Q are presented in Table 6. A LOCF, one-way repeated
measures A N O V A was conducted to compare scores on the A T Q at Time 1
(pretreatment), Time 2 (posttreatment), and Time 3 (six-month follow-up) for all
treatment completers. There was a marginally significant effect for time, Wilks'
Lambda = .445, F (2, 7) = 4.371, p = .059, multivariate partial eta squared = .555.
These data suggest a trend toward decreases in negative automatic thoughts over
time. This statistical analysis was then repeated, excluding the data of participant
number eight. The means and standard deviations, excluding participant number
eight, are presented in Table 6. There was a significant effect for time, Wilks'
Lambda = .152, F (2, 6) = 16.780, p = .003, multivariate partial eta squared = .848.
These data suggest a very large effect size for decreases in A T Q scores over time. As
with the BDI-II, a LOCF, one-way repeated measures A N O V A was conducted to
examine percent change on the ATQ. The results of this analysis suggested that there
was a significant effect for time Wilks' Lambda = .393, F (2, 7) = 5.401, p = .038,
multivariate partial eta squared = .607. These data suggest a very large effect size for
percent change in A T Q scores over time. This analysis was then repeated excluding
the data from participant number eight. As expected, there continued to be a
significant effect for time with a very large effect size, Wilks' Lambda = .086, F (2,
6) = 31.861, p = .001, multivariate partial eta squared = .914.
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Table4(Continued)
Pretreatment, Posttreatment, and Six-Month Follow-Up Means and Standard
Deviations for A T Q Scores and Percent Change
Time Period
Time 1 (Pretreatment Score) (Including
Nonresponder)

N
9

Mean
79.44

Standard Deviation
20.03

Time 2 (Posttreatment Score) (Including
Nonresponder)
Time 3 (Six-Month Follow-Up Score)
(Including Nonresponder)

9

54.00

25.62

9

52.44

28.54

Time 1 (Pretreatment Score) (Excluding
Nonresponder)
Time 2 (Posttreatment Score) (Excluding
Nonresponder)
Time 3 (Six-Month Follow-Up Score)
(Excluding Nonresponder)

8

79.50

21.41

8

48.00

19.49

8

45.25

19.97

Time 1 (Pretreatment Percent Change)
(Including Nonresponder)
Time 2 (Posttreatment Percent Change)
(Including Nonresponder)
Time 3 (Six-Month Follow-Up Percent
Change) (Including Nonresponder)

9

0

0

9

-31.64

27.02

9

-34.01

30.48

Time 1 (Pretreatment Percent Change)
(Excluding Nonresponder)
Time 2 (Posttreatment Percent Change)
(Excluding Nonresponder)
Time 3 (Six-Month Follow-Up Percent
Change) (Excluding Nonresponder)

8

0

0

8

-39.24

15.54

8

-43.16

14.16

These same analyses were then conducted with the BADS Activation subscale
for all treatment completers. The means and standard deviations are presented in
Table 7. The effect for time was not significant, Wilks' Lambda = .626, F (2, 7) =
2.089, p = .194, multivariate partial eta squared = .374. This statistical analysis was
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then repeated, excluding the data of participant number eight. The means and
standard deviations, excluding participant number eight, are presented in Table 7.
The effect for time remained non-significant, Wilks' Lambda = .603, F (2, 6) = 1.977,
p = .219, multivariate partial eta squared = .397. These data suggest that behavioral
activation did not increase over the course of time. These statistical analyses were
then repeated for percent change on the BADS Activation subscale. The results of a
LOCF, one-way repeated measures A N O V A suggested that there was not a
significant effect for time, Wilks' Lambda = .670, F (2, 7) = 1.725, p = .246,
multivariate partial eta squared = .330. This analysis was then repeated after
excluding the data from participant number eight. The results continued to remain
non-significant for time, Wilks' Lambda = .649, F (2, 6) = 1.623, p = .273,
multivariate partial eta squared = .351. These analyses suggest that the percentage
change in BADS Activation subscale scores was not significant over time.
Table 7
Pretreatment, Posttreatment, and Six-Month Follow-Up Means and Standard
Deviations for BADS Activation Subscale Scores and Percent Change
Time Period
Time 1 (Pretreatment Score) (Including
Nonresponder)
Time 2 (Posttreatment Score) (Including
Nonresponder)
Time 3 (Six-Month Follow-Up Score)
(Including Nonresponder)

N
9

Mean
17.11

Standard Deviation
7.49

9

21.56

10.37

9

24.33

11.76
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Table 4 (Continued)
Time 1 (Pretreatment Score) (Excluding
Nonresponder)
Time 2 (Posttreatment Score) (Excluding
Nonresponder)
Time 3 (Six-Month Follow-Up Score)
(Excluding Nonresponder)

8

17.75

7.74

8

22.38

10.77

8

25.50

12.00

Time 1 (Pretreatment Percent Change)
(Including Nonresponder)
Time 2 (Posttreatment Percent Change)
(Including Nonresponder)
Time 3 (Six-Month Follow-Up Percent
Change) (Including Nonresponder)

9

0

0

9

24.72

70.13

9

48.58

82.53

8

0

0

8

24.69

74.97

8

51.53

87.72

Time 1 (Pretreatment Percent Change)
(Excluding Nonresponder)
Time 2 (Posttreatment Percent Change)
(Excluding Nonresponder)
Time 3 (Six-Month Follow-Up Percent
Change) (Excluding Nonresponder)

Analyses were then conducted with the BADS Avoidance/Rumination subscale.
A LOCF, one-way repeated measures A N O V A was conducted to compare scores on
this subscale at Time 1 (pretreatment), Time 2 (posttreatment), and Time 3 (sixmonth follow-up) for all treatment completers. The means and standard deviations
are presented in Table 8. The effect for time was not significant, Wilks' Lambda =
.594, F (2, 7) = 2.394, p = .161, multivariate partial eta squared = .406. These data
suggest that there were no significant decreases in avoidant or ruminative behavior
over time. This statistical analysis was then repeated, excluding the data of
participant number eight. The means and standard deviations, excluding participant
number eight, are presented in Table 8. There was a significant effect for time,

Wilks' Lambda - .328, F (2, 6) = 6.139, p = .035, multivariate partial eta squared =
.672. These data contradict the results of the previous analysis conducted, which
included data from participant number eight, and suggest that there were in fact
significant decreases in avoidant and ruminative behavior over time. These statistical
analyses were then conducted for percent change on the BADS
Avoidance/Rumination subscale. The results of a LOCF, one-way repeated measures
A N O V A suggested that there was not a significant effect for time, Wilks' Lambda =
.558, F (2, 7) = 2.777, p = .129, multivariate partial eta squared = .442. This analysis
was then repeated after excluding the data from participant number eight. This
analysis resulted in a significant effect for time, Wilks' Lambda = .305, F (2, 6) =
6.827, p = .028, multivariate partial eta squared = .695. These results suggest that
there was a very significant effect size for percent change in BADS
Avoidance/Rumination subscale scores over time.
Table 8
Pretreatment, Posttreatment, and Six-Month Follow-Up Means and Standard
Deviations for BADS Avoidance/Rumination Subscale Scores and Percent Change
Time Period
Time 1 (Pretreatment Score) (Including
Nonresponder)
Time 2 (Posttreatment Score) (Including
Nonresponder)
Time 3 (Six-Month Follow-Up Score)
(Including Nonresponder)

N
9

Mean
24.11

Standard Deviation
3.55

9

15.56

11.94

9

15.67

12.55
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Table 4 (Continued)
Time 1 (Pretreatment Score) (Excluding
Nonresponder)
Time 2 (Posttreatment Score) (Excluding
Nonresponder)
Time 3 (Six-Month Follow-Up Score)
(Excluding Nonresponder)

8

23.75

3.62

8

12.63

8.63

8

12.50

8.77

Time 1 (Pretreatment Percent Change)
(Including Nonresponder)
Time 2 (Posttreatment Percent Change)
(Including Nonresponder)
Time 3 (Six-Month Follow-Up Percent
Change) (Including Nonresponder)

9

0

0

9

-36.83

44.48

9

-37.34

46.54

Time 1 (Pretreatment Percent Change)
(Excluding Nonresponder)
Time 2 (Posttreatment Percent Change)
(Excluding Nonresponder)
Time 3 (Six-Month Follow-Up Percent
Change) (Excluding Nonresponder)

8

0

0

8

-46.99

34.65

8

-48.50

34.57

After all LOCF, one-way repeated measures ANOVAs were conducted with
data from the A T Q and BADS, a series of Pearson Product-Moment Correlations
were conducted between the BDI-II and the ATQ, BADS, and VLQ. The results of
these correlations are combined with graphs of the results of the ATQ, BADS, V L Q
and BDI-II, which are presented below for analysis using visual inspection to
examine session-by-session changes in scores.
When including the data from participant number eight, the BDI-II and A T Q
correlated strongly with each other across treatment and follow-up (see Table 9 and
Figure 2), suggesting changes in cognition as being a plausible mechanism of action.
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Table4(Continued)
Correlations Between BDI-II and A T Q Scores (Including Participant #8)
(Significant Correlations in Bold Italics)
Pre
Tx

SI

S2

S3

S4

S5

S6

SI

S8

S9

S10

Post
Tx

1Mo
FU

3Mo
FU

6Mo
FU

r

.737

.669

.553

.757

.809

.830

.033

.018

.008

.003

.006

.850
.004

.858
.003

.945

.123

.851
.004

.861

.049

.705
.034

.738

.023

.673
.047

.707

P

.023

BDI-II and ATQ Scores (Including Participant #8)

Time
B D I - I I —»—ATQ

Figure 2. BDI-II and A T Q Scores (Including Participant #8)
However, when the data f r o m participant number eight was excluded, the
correlations between the BDI-II and A T Q only emerged later in the course of
treatment, calling in to question the likelihood that changes in cognition are
responsible for changes in symptoms of depression (see Table 10 and Figure 3).

.000
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Table4(Continued)
Correlations Between BDI-II and A T Q Scores (Excluding Participant #8)
(Significant Correlations in Bold Italics)

r
P

Pre
Tx

SI

S2

S3

S4

S5

S6

S7

S8

S9

S10

Post
Tx

1Mo
FU

3Mo
FU

6Mo
FU

.803
.017

.669
.069

.565
.144

.643

.647
.083

.491
.217

.642

.429
.289

.560

.775
.024

.745
.034

.708
.050

.710

.700
.053

.873

.086

.086

.149

.049

.005

BDI-II and ATQ Scores (Excluding Participant #8)

Time
—•— B D I - I I

— A T Q

Figure 3. BDI-II and A T Q Scores (Excluding Participant #8)
T h e same analysis was then conducted to examine the relationship between
BDI-II scores and B A D S Activation subscale scores. Both when including and
excluding data f r o m participant number eight, no consistent correlation appeared to
emerge between changes in symptoms of depression and changes in behavioral
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activation until later in treatment, suggesting that change in overt behavior is not the
mechanism through which changes in symptoms of depression are observed (see
Tables 11 and 12 and Figures 4 and 5).
Table 11
Correlations Between BDI-II and B A D S A C Scores (Including Participant #8)
(Significant Correlations in Bold Italics)
Pre
Tx

SI

S2

S3

S4

S5

S6

.077

.108

.602

.739

.569

.844

.781

.086

.023

.110

.409
.274

S7

S8

.667

.483

.598

.050

.188

.089

S9

S10

Post
Tx

1Mo
FU

3Mo
FU

6Mo
FU

.739

.690

.686

.732

.741

.681

.023

.040

.041

.023

.022

.043

r
P

BDI-II and BADSAC Scores (Including Participant #8)
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Table4(Continued)
Correlations Between BDI-II and B A D S A C Scores (Excluding Participant #8)
(Significant Correlations in Bold Italics)
Pre
Tx
r

-

SI

.1)0

.204
P

.628

.795

S2

S3

-

-

.602

.728

.114

.040

S4

S5

S6

S7

S8

S9

S10

-

-

-

-

-

-

-

.514
.193

.411
.311

.668
.070

.444

.605
.112

.720
.044

.707

.270

.050

Post
Tx

1-

Mo
FU

-.706

-

.050

.731
.040

3Mo
FU

6Mo
FU

.760
.029

.841
.009

.

BDI-II and BADSAC Scores
(Excluding Participant #8)

Time
B D I - I I - — BADSAC

Figure 5. BDI-II and B A D S A C Scores (Excluding Participant #8)
T h e correlation between the BDI-II and the B A D S Avoidance/Rumination
subscale scores was also investigated. W h e n this correlation was examined while
including the data f r o m participant number eight, a consistent correlation emerged
early in treatment between changes in symptoms of depression and changes in

.
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avoidance and rumination, suggesting that decreased avoidance and rumination is a
probable mechanism through which the effects of behavioral activation are observed
(see Table 13 and Figure 6).

Table 13
Correlations Between BDI-II and B A D S A R Scores (Including Participant #8)
(Significant Correlations in Bold Italics)
Pre
Tx

SI

S2

S3

S4

S5

S6

S7

S8

S9

S10

Post
Tx

1Mo
FU

3Mo
FU

6Mo
FU

r

.397

.571

.511

.808

.798

.742

.086

.008

.010

.022

.775
.014

.795
.010

.847

.160

.746
.021

.797

.108

.670
.048

.797

.290

.656
.055

.602

P

.010

.004

.010

BDI-II and BADSAR Scores (Including Participant #8)

Time
—•— BDI-II —•— BADSAR

Figure 4. BDI-II and BADSAC Scores (Including Participant #8)
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Interestingly, when this analysis was repeated without including the data of
participant number eight, no correlations were observed between the BDI-II and the
B A D S Avoidance/Rumination subscale, calling in to question the conclusion that
decreases in avoidance and rumination are responsible for decreases in symptoms of
depression (see Table 14 and Figure 7).
Table 14
Correlations Between BDI-II and B A D S A R Scores (Excluding Participant #8)
(Significant Correlations in Bold Italics)

r
P

Pre
Tx

SI

S2

S3

S4

S5

S6

S7

S8

S9

S10

Post
Tx

1Mo
FU

.597
.118

.631
.093

.528
.179

.625
.097

.508
.199

.574
.137

.691
.058

.539
.168

.350
.395

.686
.060

.496
.211

.601
.115

.592
.122

3Mo
FU
.599
.117

BDI-II and BADSAR Scores
(Excluding Participant #8)

i
th
Time
BDI-II —

BADSAR

Figure 7. BDI-II and B A D S A R Scores (Excluding Participant #8)

i
m

i
vo

6Mo
FU
.594
.120
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Finally, the correlation between the BDI-II and the V L Q was examined.
W h e n including the data f r o m participant number eight, a semi-consistent correlation
between decreases in symptoms of depression and increases in values-consistent
behaviors emerged in mid- to late-treatment, suggesting that changes in valuesconsistent behavior may be responsible for changes in symptoms of depression (see
Table 15 and Figure 7).
Table 15
Correlations Between BDI-II and V L Q Scores (Including Participant #8)
(Significant Correlations in Bold Italics)

r
P

S3
-.208
.591

S4
-.338
.374

S5
-.541
.133

S6

SI

S8

S9

S10

-.712

-.622
.074

-.702

-.744

-.748

.035

.022

.020

.032

BDI-II and VLQ Scores (Including Participant #8)

Time
—•— B D I - I I —"—VLQ

Figure 4. BDI-II andBADSACScores (Including Participant #8)
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However, when this same analysis was repeated without including the data of
participant number eight, only one statistically significant correlation between BDI-II
scores and V L Q scores emerged, prior to session ten of treatment (see Table 16 and
Figure 9). This finding suggests that changes in values-consistent behavior may not
actually be responsible for changes in symptoms of depression.
Table 16
Correlations Between BDI-II and V L Q Scores (Excluding Participant #8)
(Significant Correlations in Bold Italics)

r
P

S3
-.235
.575

S4
-.211
.615

S5
-.287
.491

S6
-.583
.129

S7
-.546
.161

S8
-.661
.074

S9
-.687
.060

S10
-.709

.049

Inspection of individual participant data was then conducted (please refer to
Appendices M, N, and O for individual participant graphs). The data from individual
participants is summarized in the table below. Items that are in bold, italic, and
underlined text represent that changes in a specific scale occurred the between
sessions prior to the largest decrease in BDI-II scores. Items that are in bold text
alone represent that changes in a specific scale occurred corresponding with the
largest decrease in BDI-II scores.
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BDI-II and VLQ Scores (Excluding Participant #8)

Time
—•— B D I - I I

— V L Q

Figure 9. BDI-II and VLQ Scores (Excluding Participant #8)
Table 17
Largest Changes in BDI-II, BADSAC, VLQ, BADSAR, and ATQ Scores Among
Full Responders and Partial Responders
Participant
Full Responder #1
Full Responder #2
Full Responder #3
Full Responder #4
Partial Responder #1
Partial Responder #2
Partial Responder #3

BDI-II
S1-S2
S3-S4
S1-S2
S1-S2
S3-S4
S5-S6
S1-S2

BADSAC
S5-S6
S3-S4
S2-S3
S1-S2
S3-S4
S6-S7
S3-S4

VLQ
S6-S7
S5-S6
S3-S4
S4-S5
S4-S5

BADSAR
S2-S3
S3-S4
S8-S9
S3-S4
S4-S5

ATQ
S2-S3
S3-S4
S1-S2
S1-S2
S3-S4

S3-S4

S3-S4

S1-S2

S3-S4

S1-S2

S1-S2

Examining the individual data from full responders and partial responders,
only one participant had changes in outcome measures that preceded changes in BDIII scores. Partial Responder #2 had a decrease in ATQ scores, followed by an
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increase in V L Q scores and a decrease in BADSAR scores, all of which preceded the
largest decrease in BDI-II scores for this participant. These data suggest that for this
participant, changes in negative automatic thoughts may have been most relevant to
changes in symptoms of depression, although change in values-based behavior is also
a plausible mediator.
All full and partial responders, with the exception of Full Responder #1,
experienced a large change in at least one of their outcome measures that
corresponded with the largest change in BDI-II scores for these participants. Three
participants had large changes in both B A D S A C and A T Q scores that simultaneously
changed at the same time as their BDI-II scores. Additionally, one participant
experienced a change in her A T Q score alone, which occurred at the same time as her
BDI-II score changed, and another participant experienced changes in both her A T Q
and BADSAR scores, which occurred at the same time as her BDI-II scores.
Data from individual participant graphs add a small amount of additional
support that changes in negative automatic thoughts may mediate changes in
symptoms of depression when utilizing behavioral activation as a treatment for
depression. However, given that many participants exhibited changes in outcome
measures that occurred at the same time as changes in BDI-II scores, rather than
preceding these changes, it is difficult to make conclusions about causality.
Consumer Satisfaction

and Services Sought Post-Treatment.

Finally, data on

consumer satisfaction and services sought since treatment was gathered. Three
questions regarding consumer satisfaction were embedded within each session of the
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Building a Meaningful

Life Through Behavioral Activation

Program.

Participants

were first asked, "How interesting was today's session?" Response options included
"not interesting," "somewhat interesting," and "very interesting," which were
subsequently coded as "1," "2," and "3," respectively. The average consumer
satisfaction rating on this question was 2.38, suggesting that participants had at least
moderate interest in the sessions they completed, on average. Participants were then
asked, "How helpful was today's session?" As with the previous question, response
options were "not helpful," "somewhat helpful," and "very helpful," which were
coded in a similar fashion to the previous question. The average consumer
satisfaction rating on this question was 2.28, suggesting that participants perceived
the sessions they completed to be at least somewhat helpful, on average. Finally,
participants were asked, "How encouraging was today's session?" Response options
included "not encouraging," "somewhat encouraging," and "very encouraging." The
average consumer satisfaction rating on this question was 2.25, suggesting that
participants found the sessions they completed to be at least somewhat encouraging,
on average. In addition to these three questions, participants were also asked to
complete a fifteen-item Consumer Satisfaction Survey, with response options ranging
from " 1 " (Strongly Disagree) to "5" (Strongly Agree), with higher scores representing
greater degrees of consumer satisfaction. The average rating on this measure was
3.92, suggesting a relatively high level of satisfaction with the Building a
Life Through Behavioral

Activation

program.

Meaningful
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Finally, data was obtained about services being sought at posttreatment and
follow-up. At posttreatment, of the participants who responded, three participants
were not currently receiving any services for symptoms of depression and one
participant was receiving medication/psychiatric services in the community. At onemonth follow-up, one participant continued to receive no services for symptoms of
depression, one participant was receiving combined psychotherapy and medication
services, and one participant was attending group meetings. At three-month followup, one participant continued to receive no services for symptoms of depression, two
participants were receiving psychotherapy in the community, and one participant was
continuing to use skills from the Building a Meaningful
Activation

Program.

Life Through

Behavioral

At six-month follow-up, one participant continued to receive no

services for symptoms of depression, one participant was engaging in self-care, one
participant was receiving therapy in the community, one participant was receiving
combined therapy and medication services in the community, and one participant
reported receiving other, unspecified services.
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CHAPTER V
DISCUSSION

The purposes of the present study were to test the efficacy of a computerized
behavioral activation treatment for depression and examine possible mechanisms of
action. This study intended to expand on existing treatment outcome literature
suggesting that behavioral activation is an effective intervention by testing the
efficacy of the intervention through novel treatment modality. Furthermore, this
study aimed to provide some clarity around proposed mechanisms of action of
behavioral activation treatments for depression. It was hypothesized that
computerized behavioral activation treatment would lead to significant decreases in
symptoms of depression and increases in quality of life and values-consistent
behaviors. Furthermore, it was hypothesized that homework completion would be
associated with greater reductions in symptoms of depression and that changes in
overt behaviors would be the primary mechanism by which treatment effects are
observed.
Outcomes of the Present Study. The results of this study provide preliminary
evidence for the efficacy of the Building a Meaningful
Activation

Life Through

Behavioral

computerized treatment for depression. Observed effects on the BDI-II

trended toward statistical significance when analyzing data from the entire sample of
treatment completers and these effects became statistically significant with a large
effect size upon removal of the data from the nonresponder in the study.
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Additionally, the overall response rate obtained in this study, when using the BDI-II
as a measure of response rate, the present study achieved comparable response rates
to other studies examining the efficacy of behavioral activation. A similar pattern to
that observed with the BDI-II was observed with scores f r o m other measures that
have demonstrated correlations with the BDI-II, including the ATQ and the BADS
Avoidance/Rumination subscale. Of note, these changes were not only observed at
posttreatment, but were maintained through six-month follow-up. These data provide
a tentative but promising basis for continued study of the efficacy of this specific
computerized treatment for depression. Furthermore, these data are consistent with
prior findings demonstrating the efficacy of behavioral activation (e.g. Dimidjian, et
al., 2006) and the efficacy of computerized interventions (e.g. Proudfoot, et al., 2004)
in the treatment of depression.
While the observed decrease in symptoms of depression was consistent with
the primary hypothesis of this study, the data used to examine hypothesized
mechanisms of action did not provide unequivocal support for the hypothesis that
overt changes in behavior are responsible for the observed treatment effects.
Quantitative data available from the ATQ, BADS, and VLQ, when examined both
statistically, visually, and at an individual participant level, at best suggest a tentative
conclusion that changes in negative automatic thoughts may account for observed
treatment effects. When examining data from the whole sample of treatment
completers, as well as the majority of treatment responders, changes in scores on the
ATQ and BADS Avoidance/Rumination subscales emerged as measures of plausible
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mechanisms of action, given their correlations with the BDI-II beginning in early
treatment sessions and continuing throughout treatment and the overall decreases in
each measure observed over the course of treatment and through the follow-up
assessment phase. However, when examining this same set of data without including
the data from the nonresponder in the study, these correlations were no longer found
and the correlations that were observed all were found in treatment sessions that were
subsequent to the two most precipitous decreases in BDI-II scores, observed between
sessions two and three and sessions four and five. However, individual correlations
remained when examining the individual participant data of full and partial
responders. Nonetheless, the notable changes on the A T Q over the course of
treatment and follow-up warrant some consideration of changes in negative automatic
thoughts as a possible mediator of observed treatment effects. The effects observed
on the BADS Avoidance/Rumination subscale are arguably consistent with this
finding, as the BADS Avoidance/Rumination subscale includes a number of thoughtoriented items (e.g. "I tried not to think about certain things," "I spent a long time
thinking over and over about my problems"). Adding a level of complexity to this
analysis, significant changes were also observed on the V L Q over the course of
treatment, suggesting changes in values-consistent behavior may warrant additional
consideration as a possible mediator of treatment effects of behavioral activation.
Additionally, one participant experienced changes in V L Q scores that preceded
changes in BDI-II scores, which lends some support to the possibility that changes in
values-consistent behavior may mediate treatment effects. However, this participant
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also experienced changes in the A T Q and BADSAR prior to changes in the BDI-II as
well, which complicates interpretations of what may have mediated treatment effects
for this participant. When considering the method of analysis used at an aggregated
data level, it is important to note that a session-by-session correlational analysis
interferes with the ability to make conclusions about direction of effect. Furthermore,
this method of analysis does not take in to account expectations regarding temporal
precedence. In other words, we might expect, for example, for changes on the BADS
to occur prior to changes on the BDI-II, rather than these changes occurring
simultaneously. Unfortunately, the data obtained from this study regarding plausible
mediators of treatment effects appear to only add additional complexity to the
existing literature regarding the mechanism of action of behavioral activation.
Another interesting finding of the present study was that self-reported quality
of life did not improve over the course of treatment, despite decreases in symptoms of
depression and increases in values-consistent behavior at both an aggregate and
individual level. It is curious that values-consistent behavior would increase without
seeing increases in quality of life over time. It is possible that because the QOLS and
VLQ measure two separate constructs (e.g. satisfaction with a variety of aspects of
one's life versus the extent to which one is living consistently with one's values), it
might be expected that they wouldn't necessarily correlate with each other. It is
entirely possible to be living fairly consistently with one's values, while not being
satisfied with the current circumstances of one's life. Another possible explanation
for the disconnect between the findings regarding the QOLS and the V L Q is that
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changes on the V L Q could be accounted for by smaller, more easily accomplished
behaviors (e.g. calling one's mother more frequently to live more consistently with
values pertaining to familial relationships), whereas changes on the QOLS may take
more time and effort to accomplish (e.g. finding a romantic partner, increasing
financial security). Finally, it is possible that changes that participants made in their
lives that might account for changes in symptoms of depression are not changes that
are measured by the QOLS, but are changes that are captured by the VLQ, which
more closely relates to the content of the program. In fact, it is possible that many of
the areas assessed by the QOLS are not necessarily areas that comport with valuesbased behavior for participants.
Finally, it was an unexpected finding that homework completion was not
correlated with changes in BDI-II scores when analyzing aggregated data. It was
hypothesized that the more participants engaged in the treatment process outside of
session, the more than they would benefit in terms of improvements in symptoms of
depression. A number of scenarios may account for this interesting finding. First, it
is possible that the small sample size of the study obscured the relationship between
homework completion and changes in symptoms of depression, a hypothesis that is
supported by the distribution of participants on the corresponding scatterplot.
Second, it is possible that nonspecific aspects of the program (e.g. support) may
account for the observed changes, rather than overt changes in behavior outside of
session, measured by homework completion. In fact, this hypothesized scenario may
also account for the fact that no changes were observed on the BADS Activation

subscale. Third, it is possible that participants were altering their behavior outside of
session, but not completing the actual homework assignments. In other words,
participants were engaging with the treatment process, but not in a way that was
being measured by homework completion. Finally, it is possible that the homework
completion measure was not sensitive enough to capture this hypothesized
correlation. The homework completion measure was an "all, some, or none" choice,
which may not encompass more nuanced levels of completion.
Limitations

of the Present Study. There are a number of limitations of the

present study that merit comment. First, the small sample size of the present study
should limit the extent to which firm conclusions are drawn f r o m the data presented.
Given that the intervention being utilized in the present study had not previously been
tested, the it was the intention to keep the sample size relatively small, so that any
difficulties discovered during pilot testing could be addressed accordingly prior to
providing treatment to larger groups of individuals. This decision was ultimately an
advantageous one, as many unexpected challenges were encountered in testing the
first iteration of the computerized treatment program utilized in this study.
Second, only five of the nine individuals who began treatment completed all
ten sessions of treatment. Many of the reasons for discontinuation could be addressed
in future studies. Given that one participant terminated due to problems with program
functionality, future tests of newly designed computer treatment programs should be
extensively tested for functionality prior to beginning pilot testing. Future researchers
could begin by having graduate students, research assistants, and other non-clinical
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populations test the program for functionality, after which it could be pilot tested with
a clinical population. The most common reason for termination, however, was the
end of the school semester. Future researchers should consider time frames for
recruitment to accommodate for the possibility that changes in schedules may lead to
premature termination. As such, it would be recommended to commence recruitment
at the beginning of semesters, when possible.
Third, the present study experienced some data loss, due to a period during
which the program server was offline, without the knowledge of the research team.
The computer was the sole source for a few pieces of data, including the VLQ,
information regarding homework completion, and information regarding the extent to
which the program was interesting, helpful, and encouraging. Future studies should
consider having all measures be completed using pen and paper to prevent data loss.
One concern with this approach is that participants may have the undue burden of
completing the same measure twice, if the measure is also embedded in the computer
program itself. This could be addressed through having a research assistant sit with
the participant while he or she completes the measure and write down his or her
responses. Alternatively, other measures could be taken to ensure that participant
responses are being recorded by the computer, including programming a back-up
system that increases the likelihood that participant responses will be recorded in at
least one database or location on the computer.
Fourth, some aspects of the measures utilized in the present study may limit
the ability to obtain information about treatment effects and consumer satisfaction.

The VLQ was only administered during sessions three through ten of treatment,
which limits the conclusions that can be made about values-based behaviors prior to
and early in treatment, as well as changes in values-based behaviors after treatment.
Given the importance of continuing to gather data regarding plausible mechanisms of
action of behavioral activation, the lack of data available from the VLQ is
unfortunate, especially given that many participants experienced changes in
symptoms of depression within the first two sessions of treatment, before the V L Q
was administered. Additionally, many of the measures administered by the computer
only had three response options, which may not capture more nuanced responses
regarding homework completion and consumer satisfaction.
Future Investigation

and Conclusion.

The most obvious future direction for

additional research on the Building a Meaningfid

Life Through Behavioral

Activation

computerized treatment for depression is to continue to test the program's efficacy
with a larger sample size. Clearly, the small sample size limits the conclusions that
can be made regarding the efficacy of the program being tested and the
generalizability of the preliminary findings of this study to different populations and
settings. As many of the difficulties with program functionality have been addressed
throughout the present study and in the time since the completion of data collection,
further testing with clinical populations seems warranted at this time. In addition to
allowing for more definitive conclusions to be made about the efficacy of the
Building a Meaningfid

Life Through Behavioral

Activation

treatment, studies with an

increased sample size may also be able to provide additional clarity with regard to

84
some of the other hypotheses tested in this study (e.g. hypotheses regarding
mechanism of action), as well as test additional new hypotheses. For example, given
the novelty of computerized interventions for depression, it may be interesting to test
hypotheses examining populations for which computerized interventions are more
and less effective.
Second, future researchers may want to examine the efficacy of the Building a
Meaningful

Life Through Behavioral

Activation

program in settings other than a

university campus. Given the limited access to therapy services in many settings,
including community mental health clinics, short-term inpatient psychiatric units, and
primary care health settings, testing computerized interventions in these locations
may provide evidence for cost-effective enhancements to the current level of care
being provided. While it may not be plausible for these settings to employ mental
health professionals capable of providing therapy on a full-time basis, it is more likely
that these settings may be able to accommodate the cost of a computerized treatment
program for depression, should this type of approach demonstrate efficacy with the
populations served in these settings.
Third, if the Building a Meaningful

Life Through Behavioral

Activation

program continues to demonstrate efficacy, studies comparing the program to other
active treatments is warranted. Previous research has suggested that the effects of
computerized treatment programs are comparable to the effects of therapistadministered treatments. Future researchers should examine whether this outcome is

found when comparing computerized behavioral activation programs to other active
treatments.
Fourth, should additional studies demonstrate efficacy of computerized
behavioral activation treatments for depression, future researchers may want to
consider creating optional modules to include as part of the computerized treatment
program, targeted at addressing disorders that are commonly comorbid with
depression. Given the substantial comorbidity between mood and anxiety disorders,
modules addressing some of the most common anxiety disorders may be a logical
first step for expansion of computerized behavioral activation treatments.
Finally, future researchers may wish to consider ways to enhance the
measurement of both proposed mechanisms of action, homework completion, and
consumer satisfaction, with regard to computerized behavioral activation treatments.
As mentioned previously, the V L Q was only administered throughout a limited
portion of treatment. Given the potential relevance of this measure to examining
mechanisms of action of behavioral activation, it is recommended that the V L Q be
administered f r o m pretreatment through follow-up assessment phases. Additionally,
given the importance of assessment of homework completion, more nuanced
approaches to the measurement of homework completion, perhaps including very
detailed assessments of values-based behaviors from week-to-week is warranted.
Finally, future researchers may consider more detailed measurements of consumer
satisfaction, for purposes of additional program improvements.

In conclusion, the results of this study provide very preliminary evidence for
the efficacy computerized behavioral activation treatments for depressive disorders.
Future research this area should allow for continued refinements of this treatment
approach, which may provide some avenues for reducing lack of access to mental
health services, should further findings continue to demonstrate efficacy of this
specific treatment.
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Appendix A
Beck Depression Inventory - II (BDI-II)
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The Beck Depression Inventory - II is copyright by Aaron T. Beck, 1996.
Individuals interested in obtaining information regarding the Beck Depression
Inventory - II should contact Pearson, Attn: Customer Service, 19500 Buiverde Road,
San Antonio, T X 78259-3701.
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Appendix B
Revised Hamilton Rating Scale for Depression (RHRSD)
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The Revised Hamilton Rating Scale for Depression is copyrighted by W. L. Warren,
1994. Individuals interested in obtaining information regarding the Revised Hamilton
Rating Scale for Depression should contact Western Psychological Services, 12031
Wilshire Boulevard, Los Angeles, CA 90025-1251.

Appendix C
The Structured Clinical Interview for DSM-IV Axis I Disorders

The Structured Clinical Interview for DSM-IV Disorders is copyrighted by Michael
B. First, 1997. Individuals interested in obtaining information regarding the
Structured Clinical Interview for DSM-IV Disorders should contact American
Psychiatric Publishing, Inc., 1000 Wilson Boulevard, Suite 1825, Arlington, VA
22209-3901.

Appendix D
The Behavioral Activation for Depression Scale
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Individuals interested in obtaining information regarding the Behavioral Activation
for Depression Scale should contact J. W. Kanter, Department of Psychology,
University of Wisconsin-Milwaukee, PO Box 413, Milwaukee, W I 53201.
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Appendix E
Automatic Thoughts Questionnaire (ATQ)

Individuals interested in obtaining information regarding the Automatic Thoughts
Questionnaire should contact S. D. Hollon or P. C. Kendall, Cognitive Assessment
Project, Department of Psychology, University of Minnesota, 75 East River Road,
Minneapolis, M N 55455.
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Appendix F
Quality of Life Scale (QOLS)

Individuals interested in obtaining information regarding the Quality of Life Scale
should contact C. S. Burckhardt, Oregon Health Sciences University, 3181 S.W. Sam
Jackson Park Road, Portland, OR 97201.

Appendix G
Initial Assessment Information Form
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Initial Assessment Information Form for Participant Number.

Age:

Date of Birth:
Race/Ethnicity:
1 = Caucasian/White

2 = African-American

3 = Hispanic/Latino

4 = Asian-American

5 = Native American

6 = Arab-American

7 = Alaskan American

8 = Multiracial

9 = International / Non-US Resident
10 = Other
Sex:
1 = Male

2 = Female

Marital Status:
1 = Single

2 = Married

3 = Domestic Partnership

4 = Engaged

5 = Separated

6 = Divorced or Annulled

7 = Widowed

8 = Other

Occupational Status:
1 = Currently Employed

2 = Unemployed

3 = On Disability

4 = Stay at Home Parent

5 = Retired

6 = Other

1 = Under $5,000

2 = $5,000 - $9,999

3 = $10,000 - $14,999

4 = $15,000 - $24,999

5 = $25,000 - $34,999

6 = $35,000-$49,999

7 = $50,000 - $74,999

8 = $75,000 - $99,999

9 = $100,000 and over

Household Income:

101
Education Level:
1 = Less than 7th Grade

2 = 7lh - 12th Grade
(Did Not Graduate)

3 = Graduated High
School

4 = GED

5 = Some College

6 = Graduated 2-Year
College or Technical
School

7 = Graduated 4-Year
College

8 = Some Graduate School

9 = Graduate Degree
(e.g. Ph.D., M.A., M.D.)

PREVIOUS Treatment(s) for Depression (Circle All That Apply):
1 = None

2 = Medications

3 = Individual Therapy

4 = Group Therapy

5 = Support Group

6 = Case Management

7 = Pastoral Care

8 = Hospital (Inpatient or Partial Hospitalization)

9 = Other

CURRENT Treatment(s) for Depression (Circle All That Apply):
1 = None

2 = Medications

3 = Individual Therapy

4 = Group Therapy

5 = Support Group

6 = Case Management

7 = Pastoral Care

8 = Hospital (Inpatient or Partial Hospitalization)

9 = Other
Current Psychotropic Medications:
Selective Serotonin Reuptake Inhibitors
Citalopram (Celexa)
Fluoxetine (Prozac, Sarafem)
Paroxetine (Paxil, Pexeva)

(SSRIs)
Escitalopram (Lexapro)
Fluvoxamine (Luvox, Faverin, Dumyrox)
Sertraline (Zoloft)

Tricyclic Antidepressants

(TCAs)

Amitriptyline
Clomipramine (Anafranil)
Doxepin
Nortriptyline (Pamelor)
Trimipramine (Surmontil)
Monoamine

Oxidase Inhibitors

Amoxapine
Desipramine (Norpramin)
Imipramine (Tofranil)
Protriptyline (Vivactil)

(MAOIs)

Isocarboxazid (Marplan)
Rasagiline (Azilect)
Tranylcypromine (Parnate)

Phenelzine (Nardil)
Selegiline (Eldepryl, Zelapar)

SSNRIs (Selective Serotonin and Norepinephrine
Duloxetine (Cymbalta)
Atypical

Reuptake

Inhibitors)

Venlafaxine (Effexor)

Antidepressants

Buproprion (Wellbutrin, Zyban)
Antipsychotics
Aripiprazole (Abilify)
Clozapine (Clozarilm FazaClo)
Haloperidol (Haldol)
Olanzapine (Zydis, Zyprexa)
Risperidone (Risperdal)
Thiothixene (Navane)
Ziprasidone (Geodon)
Mood

Chlorpromazine (Thorazine)
Fluphenazine (Prolixin)
Loxapine (Loxitane)
Quetiapine (Seroquel)
Thioridazine (Mellaril)
Trifluoperazine (Stelazine)

Stabilizers/Anticonvulsants
Gabapentin (Neurontin)
Lithium (Eskalith, Lithobid)
Tiagabine (Gabitril)
Valproic Acid (Depakote)

Lamotrigine (Lamictal)
Oxcarbazepine (Trileptal)
Topiramate (Topamax)

Anxiolytics/Benzodiazepines
Alprazolam (Xanax)
Chlordiazepoxide (Librium)
Lorazepam (Ativan)

Buspirone (BuSpar)
Clonazepam (Klonopin)
Oxazepam (Serax)
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Number of Weeks You Have Been Taking Antidepressant Medications:
weeks
How Many Years of Experience Do You Have With Computers?
year(s)
How Comfortable Are You With a Computer?
1

2

3

4

5

6

7

8

Completely Uncomfortable

9

10

Completely Comfortable

How Much Knowledge Do You Have About Computers?
1

2

No Knowledge

3

4

5

6

7

8

9

10

Extensive Knowledge

On Average, How Many Hours Do You Use a Computer Each Week?
hour(s)

Appendix H
Additional Services Form
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Additional Services Form for Participant Number
Please indicate what services you have received since completing your final session
of the computerized treatment for depression.

1 - None

2 = Therapy in the Community

3 = Medication/Psychiatric Services in the Community

4 = Combined Therapy and Medication Services in the Community

5 = Investigating Treatment Options

6 = Self-Care

7 = Group Meetings

8 = Continuing to Use Skills From the Computerized Treatment for Depression

9 = Other (Please Describe)

Appendix I
Phone Script
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Phone Script
(Research Assistant): Hello. My name is
?

. May I speak with

YES: (wait for phone to be given to potential participant and/or begin script
below)
NO: Do you know a time during which I may be able to reach him/her?
YES: (MAKE NOTE OF TIME). Thank you for your assistance.
NO: Thank you for your time, I will call back later.
(Research Assistant): Hello. My name is
and I am a research
assistant at Western Michigan University. I am calling because you left a message on
our laboratory phone regarding a depression study we are conducting. Are you
interested in learning more about the study?
NO: Okay, thank you for your time.
Y E S : If you decide to participate and qualify for the study, you would
receive a computerized behavioral activation treatment for depression called
"Building a Meaningful Life Through Behavioral Activation". The treatment
involves learning new strategies to alleviate your symptoms of depression and has
been previously shown to be effective for many people who are experiencing
symptoms of depression. Treatment would take place over the course of
approximately two-and-a-half months and would involve ten weekly sessions of
behavioral activation therapy, administered by a computer with the aid of a research
assistant. These sessions will be approximately forty-five minutes to one-and-onehalf hours in length. In addition to attending these weekly sessions, it is also
expected that you will practice the strategies learned in therapy over the course of
your week. You would also be asked to attend two initial assessment appointments
and four follow-up assessment appointments to thoroughly evaluate your symptoms
of depression, the last of which would occur six months after the completion of
treatment. Do you have any questions about participating in this research project?
YES: (ANSWER ANY QUESTIONS). If you are still interested in
learning more about the study, the next step would be to schedule an initial
assessment appointment. This appointment should take approximately one half-hour
to complete. During this assessment appointment, you will be asked to read and sign
an informed consent document and complete two self-report measures. Would you
be interested in scheduling an initial assessment appointment?
N O : If you are still interested in learning more about the study, the
next step would be to schedule an initial assessment appointment. This appointment
should take approximately one half-hour to complete. During this assessment
appointment, you will be asked to read and sign an informed consent document and

complete two self-report measures. Would you be interested in scheduling an initial
assessment appointment?
NO: Okay. Thank you for your time. Goodbye.
YES: Okay, at this time I would like to set up your initial
screening appointment. (SET UP A D A T E AND TIME). Would you like to receive
a reminder phone call? (IF YES, M A K E REMINDER P H O N E C A L L
A R R A N G E M E N T ) . Thank you for your time.

Appendix J
Informed Consent Document
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"Testing the Efficacy of a Computerized Behavioral Activation Protocol in the
Treatment of Depressive Disorders"
Western Michigan University
Department of Psychology
Informed Consent to Participate in Research
Principal Investigator: C. Richard Spates, Ph.D.
Student Investigator: Alyssa Kalata, M.A.
Purpose
You have been invited to participate in research project entitled "Testing the Efficacy
of a Computerized Behavioral Activation Protocol in the Treatment of Depressive
Disorders." This research is intended to test the effectiveness of a psychological
therapy administered by a computer to treat symptoms of depression. This
psychological therapy has been shown to be effective with many people when
administered by a therapist. We are doing this study because we would like to know
how effective this psychological therapy is when administered by a computer. This
project will serve as Alyssa Kalata's dissertation study.
Participation
If you agree to participate in this study, you will be asked to complete a brief initial
assessment appointment at today's appointment, during which you will complete a
personal information form and one measure of your symptoms of depression. This
brief initial assessment will take approximately one half-hour to complete. You will
then be asked to complete a comprehensive second assessment approximately one
week from today, during which you will complete three measures of your examining
your symptoms of depression and methods of coping, one measure examining your
quality of life and adaptive functioning, and a psychological interview. This
comprehensive second assessment appointment will take approximately two hours to
complete. Based on the results of this comprehensive second assessment
appointment, it will be determined if you qualify to participate in the study. Those
individuals who meet criteria for a depressive disorder, as determined by two of the
primary assessment measures for the study, will be eligible to participate. A
diagnosis of bipolar disorder, psychotic disorder, active substance abuse, mental
retardation and/or dementia will exclude you from the study. You will also be
excluded from the study if you are currently receiving therapy services for your
symptoms of depression or if you are taking antidepressant medications and have
been taking these medications for less than eight weeks. Regardless of whether you
qualify for participation in the study, you will be provided with a list of local mental
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health service providers, including some locations that offer reduced-fee services.
These may be an alternative to participation in the present study.
Procedures
If you qualify for participation in the study, you will be asked to begin treatment
approximately one week after your comprehensive second assessment appointment.
You will receive a computerized behavioral activation treatment for depression,
which involves ten weekly treatment sessions, lasting approximately forty-five
minutes to one-hour each. In this behavioral activation therapy, you will be guided to
look at how your behavior impacts your mood and your symptoms of depression, and
you will be assisted in altering your behavior such that it has more positive effects in
reducing or eliminating your symptoms of depression. This treatment will be
administered with the aid of the researcher or a research assistant. Each week, you
will be asked to complete the three measures of your symptoms of depression and
methods of coping. If you are found to be symptomatic at the end of the ten weeks of
treatment, or should you decide during the course of treatment that you no longer
wish to participate in treatment, appropriate referrals to mental health practitioners in
the area will be provided. You will be responsible for the cost of any treatment
sought outside of this study.
One week after the completion of the ten weeks of treatment, you will be asked to
come in and complete the three measures examining your symptoms of depression
and methods coping, the one measure examining your quality of life and adaptive
functioning, the psychological interview completed prior to treatment, a form asking
about any current mental health treatments you are receiving, and a consumer
satisfaction survey. One, three, and six months after treatment, you will be asked to
complete this same battery of measures, with the exception of the consumer
satisfaction survey.
Risks
As in all research, there may be unforeseen risks to you as a participant. One
potential risk of your participation in this study is that you may experience unpleasant
emotions, including anger, frustration, anxiety, depression, and disappointment, as
you recall your problems and experiences and actively engage in behaviors in order to
reduce your depression. Should emergency care become necessary, the research team
is prepared to provide you with appropriate referrals, however you will be responsible
for the cost of any emergency care that you may choose to seek.
Benefits
The primary potential benefit of participation in this study is the alleviation or
elimination of symptoms of depression. This may occur through the using different
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techniques and strategies that you will learn during your weekly sessions of
behavioral activation therapy. Furthermore, knowledge gained f r o m this study may
lead to the development of more effective, accessible, and affordable treatments for
depression, which may in turn help other individuals experiencing symptoms of
depression.
Confidentiality
All information obtained from you is confidential. All paperwork that you complete
for purposes of this study will include your participant number instead of your name
and will be stored in a locked cabinet in the laboratory of the researcher. The
researcher will maintain a list with your named matched to your corresponding
participant number in a different locked cabinet located within the laboratory. This
list will be retained for the duration of the study and will be destroyed after all of the
data f r o m the study is analyzed. A signed consent document and all paperwork that
you complete for purposes of the study will be retained for at least three years in a
locked cabinet in the laboratory of the researcher. You will be given a signed copy of
this consent form for your records.
Problems or Questions
You may refuse to participate or quit at any time during the study without prejudice
or penalty. If you have any questions or concerns about this study, you may contact
either Dr. C. Richard Spates at (269) 387-4329 or Alyssa Kalata at (269) 387-4332.
You may also contact the Chair of the Human Subjects Institutional Review Board at
(269) 387-8293 or the Vice President of Research at (269) 387-8298 if questions or
problems arise during the course of the study. This consent document has been
approved for use for one year by the Human Subjects Institutional Review Board
(HSIRB) as indicated by the stamped date and signature of the board chair in the
upper right corner. Do not participate in this study if the stamped date is more than
one year old.
Your signature below indicates that you have read and/or had explained to you the
purpose and requirements of the study and that you agree to participate.

Signature

Date

Consent obtained by:
Signature of researcher

Date
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Appendix K
Individual Participant BDI-II and RHRSD Graphs
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Responder #3 BDI-II (Primary Axis) and RHRSD
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Partial Responder #3 BDI-II (Primary Axis) and RHRSD
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(Secondary Axis) Scores

"
Time
— • — BDI-II — • — RHRSD

- th i

i t us
m

118
Nonresponder #2 BDI-II (Primary Axis) and RHRSD
(Secondary Axis) Scores

Time
BDI-II — • — RHRSD
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Appendix L
Individual Participant QOLS and BDI-II Graphs
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Responder #1 QOLS (Primary Axis) and BDI-II
(Secondary Axis) Scores
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QOLS (Tot.)
•e—QOLS (P Subscale)
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Responder #2 QOLS (Primary Axis) and BDI-II
(Secondary Axis) Scores

Time
QOLS (Tot.)

— • — Q O L S (R Subscale) — * — QOLS (H Subscale)

QOLS (P Subscale) — * — BDI-II
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Responder #3 QOLS (Primary Axis) and BDI-II
(Secondary Axis)

Time
QOLS (Tot.)

— • — QOLS (R Subscale) —*—QOLS (H Subscale)

QOLS (P Subscale) — * — BDI-II

Responder #4 QOLS (Primary Axis) and BDI-II
(Secondary Axis) Scores

Time
QOLS (Tot.)

— • — Q O L S (R Subscale) — * — QOLS (H Subscale)

QOLS (P Subscale) — * — BDI-II
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Partial Responder #1 QOLS (Primary Axis) and BDI-II
(Secondary Axis) Scores

Time
QOLS (Tot.)

— • — QOLS (R Subscale) — « — QOLS (H Subscale)

QOLS (P Subscale) — * — BDI-II

Partial Responder #2 QOLS (Primary Axis) and BDI-II
(Secondary Axis) Scores

Time
QOLS (Tot.)

— • — Q O L S (R Subscale) — * — QOLS (H Subscale)

QOLS (P Subscale) — * — BDI-II
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Partial Responder #3 QOLS (Primary Axis) and BDI-II
(Secondary Axis) Scores

Time
—•—QOLS (Tot.)

—•—QOLS (R Subscale) — * — QOLS (H Subscale)

— o — QOLS (P Subscale) — * — BDI-II

Nonresponder #1 QOLS (Primary Axis) and BDI-II
(Secondary Axis) Scores

Time
QOLS (Tot.)

—•—QOLS (R Subscale) — * — QOLS (H Subscale)

QOLS (P Subscale) — * — BDI-II
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Nonresponder #2 QOLS (Primary Axis) and BDI-II
(Secondary Axis) Scores

Time
— • — Q O L S (Tot.)

— • — Q O L S (R Subscale) —*—QOLS (H Subscale)

— b — QOLS (P Subscale) — * — BDI-II
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Appendix M
Individual Participant V L Q and BDI-II Graphs
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Responder #3 VLQ (Primary Axis) and BDI-II
(Secondary Axis) Scores

Time
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Responder #4 VLQ (Primary Axis) and BDI-II
(Secondary Axis) Scores
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(Secondary Axis) Scores
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Appendix N
Individual Participant ATQ Graphs
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Appendix O
Individual Participant BADS Graphs
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